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Youth with epilepsy are at an increased risk for developing anxiety when compared 
to healthy youth (Alwash, Hussein, & Matloub, 2000; Jones et al., 2007; Russ et al., 2012) 
and when compared to youth with other chronic health conditions (Pinquart & Shen, 2011). 
Parents have become a significant focus of research examining the environmental risk and 
protective factors for anxiety in healthy children (Creswell, Murray, & Cooper, 2011; 
Gregory & Eley, 2007), and this is an area of growing research in youth with epilepsy 
(Jones & Reilly, 2016; Rodenburg, Meijer, Dekovic, & Aldenkamp, 2006; Schraegle & 
Titus, 2017a). The following study aimed to examine the medical and psychosocial risk 
factors for anxiety in youth with epilepsy.  
Participants included 121 children and adolescents with epilepsy at a tertiary 
outpatient clinic in Central Texas who were referred by their neurologists for a 
neuropsychological evaluation to assist with treatment planning. Parent perceptions of 
stigma and parent illness cognitions were examined to determine their relationship with 
parent report of anxiety, seizure-related variables, and parent history of psychopathology. 
 vii 
Using multiple regression, parent perceptions of stigma were a statistically significant 
predictor of parent reported child anxiety. Additional moderation analysis suggested that 
there is an interaction between parent perceptions of stigma and seizure severity; at higher 
levels of seizure severity, higher parent perceptions of stigma were related to higher parent 
reported features of anxiety. This suggests the potential for parent perceptions of stigma to 
play an important role in anxiety in pediatric epilepsy, particularly in the context of high 
seizure severity. Additionally, parent perceptions of stigma, parent illness cognitions, and 
parent reported child anxiety were all related to parent reported quality of life, suggesting 
the importance of addressing these psychosocial factors to improve quality of life in youth 
with epilepsy. 
 viii 
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Chapter 1: Introduction 
 
Epilepsy is a neurological disorder characterized by a predisposition to generate 
seizures (Fisher et al., 2014). Approximately 1% of children are diagnosed with epilepsy, 
making it the most common chronic neurologic condition in childhood (Aaberg et al., 2017; 
P. R. Camfield & Camfield, 2015; Russ et al., 2012). Epilepsy places a considerable burden 
on society and in the United States the economic burden of epilepsy is estimated to be 9.6 
to 12.5 billion dollars annually (Begley et al., 2000; Institute of Medicine, 2012; Yoon, 
Frick, Carr, & Austin, 2009). The etiology of epilepsy is diverse and includes structural, 
genetic, infectious, metabolic, immune, and unknown causes. While seizures are the 
defining feature of epilepsy, the cognitive, social, and emotional burden that can be 
associated with the underlying brain dysfunction can have a significant impact on quality 
of life in youth with epilepsy (Fisher et al., 2014).  
Epilepsy is considered a disease of brain networks, wherein seizures are just one 
symptom of brain dysfunction (Smith, 2016). Youth with epilepsy are at increased risk for 
cognitive difficulties because of underlying brain dysfunction and due to the effects of 
seizures and AEDs on developing brains (Institute of Medicine, 2012). There is a greater 
risk for negative psychosocial outcomes in epilepsy, such as lower social competence, 
more school problems, and limited activity when compared to healthy children (Russ et al., 
2012). Epilepsy affects social functioning by limiting an individual’s participation in 




When compared to healthy children or youth with other chronic health conditions, 
youth with epilepsy are at an increased risk for a variety of psychopathologies, including 
anxiety, depression, attention-deficit/hyperactivity disorder, and autism (Austin et al., 
2011; Caplan et al., 2005; Dunn, Austin, & Perkins, 2009; Reilly, Kent, & Neville, 2013). 
Seizure related variables (e.g., high seizure frequency, poor seizure control, and multiple 
anti-epileptic medications [AEDs]) and psychosocial factors (e.g., stigma, coping, and 
family functioning) are implicated in the increased risk of psychopathology in youth with 
epilepsy (Caplan et al., 2004; Dunn & Austin, 2004; Reilly et al., 2013). 
Youth with epilepsy are at a markedly increased risk for developing anxiety when 
compared to healthy controls (Alwash, Hussein, & Matloub, 2000; Jones et al., 2007; Russ 
et al., 2012) and when compared to youth with other chronic health conditions (Pinquart & 
Shen, 2011). However, despite its prevalence, anxiety has been referred to as the 
“forgotten” disorder in epilepsy because it has been widely ignored in the epilepsy 
literature (Gandy et al., 2015). The etiology of anxiety in pediatric epilepsy appears to be 
multifactorial and likely involves a variety of biological, psychosocial, and familial risk 
and protective factors (Jones et al., 2015).  
There is emerging evidence that anxiety and epilepsy have a bidirectional 
relationship, as features of anxiety occasionally precede the onset of seizures, suggesting a 
common underlying biological vulnerability (Adelöw, Andersson, Ahlbom, & Tomson, 
2012;  Jones et al., 2007; Kanner, 2009). Higher symptoms of anxiety in youth with 




pathways that create vulnerabilities to internalizing psychopathology. Higher symptoms of 
anxiety in youth with epilepsy may also be attributable to seizure-related variables, such as 
taking more than one AED (i.e., polytherapy), high seizure frequency, or poor seizure 
control (Reilly et al., 2013). 
 There are also a variety of psychosocial variables that are unique to youth with 
epilepsy that make them more vulnerable to anxiety. Children with epilepsy are often 
confronted with the unpredictable nature of seizures, which while anxiety provoking on its 
own, can be compounded by reduced control of the environment and parental 
overprotectiveness (Pinquart & Shen, 2011). Youth with epilepsy may also experience 
social anxiety because of the increased risk for peer rejection and victimization and the 
social stigma of epilepsy (Davies, Heyman, & Goodman, 2003; Pinquart & Shen, 2011). 
These psychosocial complications create a difficult social and family environment that 
includes elevated stress, restriction of activities, and isolation (Ellis, Upton, & Thompson, 
2000).  
Parents have become a significant focus of research examining the environmental 
risk and protective factors for anxiety in healthy children (Creswell et al., 2011; Gregory 
& Eley, 2007), and this is an area of budding research in youth with epilepsy as well (Jones 
& Reilly, 2016; Rodenburg, Meijer, Dekovic, & Aldenkamp, 2006; Schraegle & Titus, 
2017a). Recent research has demonstrated that parent history of psychopathology is related 
to anxiety in youth with epilepsy (Adewuya & Ola, 2005; Jones & Reilly, 2016; Schraegle 




et al., 2006). Conversely, positive parent-child relationships have been found to be related 
to lower internalizing symptoms (Rodenburg et al., 2006). Research regarding parent 
factors that influence anxiety in youth with epilepsy is emerging but remains limited, and 
significant work is needed to match the understanding of factors that impact the 
development of anxiety in children (Murray, Creswell, & Cooper, 2009).  
Anxiety has important implications for the quality of life in youth with epilepsy. In 
the general population, individuals with anxiety report lower quality of life, and successful 
treatment of anxiety is associated with improvements in quality of life (Hofmann, Wu, & 
Boettcher, 2014; Olatunji, Cisler, & Tolin, 2007). Research in youth with epilepsy suggests 
that internalizing symptoms have a more negative impact on quality of life than other 
demographic or epilepsy-related variables (Stevanovic, Jancic, & Lakic, 2011). However, 
more research is needed to elucidate the medical and psychosocial risk factors of anxiety 
to improve quality of life in youth with epilepsy (Scott, Sharpe, Hunt, & Gandy, 2017).  
A recent International League Against Epilepsy Task Force report (Dunn et al., 
2016) suggested that it is important to assess for reversible causes of anxiety in patients 
with epilepsy, and Ekinci et al. (2009) emphasized the importance of investigating family 
factors to identify opportunities for intervention and successful treatment that can improve 
health-related quality of life. Research grounded in theory is needed to provide greater 
insight into the risk and protective factors for anxiety, and while individuals with epilepsy 
experience high levels of stigma, research examining the relationship between stigma and 




and important context for the development of anxiety, and to date, no research has 
examined how parent illness cognitions may impact anxiety in youth with epilepsy. 
Similarly, while parental psychopathology is a known risk factor for anxiety in the general 
population, research on the genetic and environmental influences of anxiety in youth with 
epilepsy is sparse. 
The proposed research study aims to examine the medical and psychosocial risk 
factors for anxiety in youth with epilepsy. Participants included children and adolescents 
with epilepsy at a tertiary outpatient clinic in Central Texas who were referred by their 
neurologists for a neuropsychological evaluation to assist with treatment planning. Parent 
perceptions of stigma and parent illness cognitions were examined to determine their 
relationship with parent reported features of anxiety, seizure-related variables, and parent 
history of psychopathology. Finally, this research reviews the impact of parent reported 




Chapter 2: Literature Review 
 This chapter will provide an overview of epilepsy, anxiety, and the current 
understanding of anxiety within pediatric epilepsy. It will begin with a description of 
epilepsy and its prevalence in youth and provide a brief overview of the etiology, 
classification, and treatment of epilepsy and will conclude with outcomes in pediatric 
epilepsy. Next, this review will provide a description of anxiety and its prevalence in youth, 
with an overview of the etiology of anxiety, associated risk and protective factors, 
treatment options, and outcomes for youth with anxiety. Finally, this review will describe 
the literature that examines the relationship between anxiety and epilepsy and the 
prevalence of anxiety symptoms in individuals with epilepsy. Various biological and 
environmental factors that place youth with epilepsy at greater risk for anxiety will be 
considered, along with a discussion of gaps in our understanding of anxiety within pediatric 
epilepsy. The chapter will conclude with the research questions and hypotheses related to 
how parent factors influence anxiety in youth with epilepsy.  
Epilepsy 
  Epilepsy is a neurological condition characterized by the occurrence of 
unpredictable seizures (Institute of Medicine, 2012). An epileptic seizure is caused by 
neuronal activity in the brain that is abnormal and excessive; it is characterized by variable 
signs or symptoms dependent on the location of the neuronal activity (Fisher et al., 2014). 




while epilepsy is the disease associated with spontaneous and recurring seizures (Fisher et 
al., 2014). The Institute of Medicine (2012) considers epilepsy a spectrum of disorders that 
can vary in severity, type, and impact on individuals affected.  
Incidence, prevalence, cost, and burden of pediatric epilepsy. Epilepsy is the 
most common chronic neurologic condition in childhood, affecting approximately 1% of 
children (Aaberg et al., 2017; P. R. Camfield & Camfield, 2015; Russ et al., 2012). An 
estimated 6.8 million people have been diagnosed with epilepsy and 5.7 million people 
have active epilepsy in developed countries (Ngugi, Bottomley, Kleinschmidt, Sander, & 
Newton, 2010). According to a recent Norwegian study, in the first ten years of life, 
approximately 1 out of every 150 children will be diagnosed with epilepsy (Aaberg et al., 
2017). Incidence rates in children range from 41-187/100,000 (C. S. Camfield, Camfield, 
Gordon, Wirrell, & Dooley, 1996; P. R. Camfield & Camfield, 2015; Mung’ala-Odera et 
al., 2008). There is a higher incidence of epilepsy in the first year of life and in rural and 
underdeveloped countries (P. R. Camfield & Camfield, 2015). Researchers suggest that the 
incidence of epilepsy is declining in countries with higher incomes due to the reduced risk 
of infection and traumatic brain injury that cause epilepsy (Aaberg et al., 2017). The 
prevalence of epilepsy ranges from 3.2-6.7/1,000 children with a median prevalence of 
active pediatric epilepsy of 4.7/1,000 (P. R. Camfield & Camfield, 2015; Ngugi et al., 
2010). The economic burden of epilepsy is estimated to be 9.6 to 12.5 billion dollars 
annually in the United States; this includes direct costs of hospitalizations and indirect costs 




 Etiology. The etiology of epilepsy is diverse and includes structural, genetic, 
infectious, metabolic, immune, and unknown etiologies. Structural abnormalities of the 
brain that are visible on neuroimaging (e.g., lesions) may cause seizures, and typical causes 
of structural abnormalities include stroke, traumatic brain injury, infections, and 
malformations of cortical development (Scheffer et al., 2017). Infections (e.g., meningitis, 
encephalitis) are common and preventable risk factors for epilepsy (Vezzani et al., 2016). 
Certain genetic mutations (known or presumed), an array of metabolic disorders, and 
immune disorders may also cause epilepsy (Scheffer et al., 2017). While there are a 
multitude of etiologies of epilepsy, the cause of epilepsy is unknown in about 50% of 
children (P. R. Camfield & Camfield, 2015). An individual’s epilepsy can have multiple 
etiologies, and each etiology has implications for treatment (Scheffer et al., 2017). 
 Diagnosis. According to the ILAE, epilepsy is diagnosed in one of three ways: (a) 
two or more unprovoked seizures that occur more than a day apart; (b) one unprovoked 
seizure with >60% probability of another seizure occurring in the next ten years; or (c) 
diagnosis of an epilepsy syndrome (Fisher et al., 2014). Unprovoked seizures imply the 
“absence of a temporary or reversible factor” that lowers the threshold for seizures on an 
otherwise normal brain (Fisher et al, 2014). Examples of provoked seizures include 
seizures associated with concussion, fever, or alcohol withdrawal (Fisher et al, 2014).  
Classification. Epilepsy classification is a complex process that can be based on a 
variety of factors. Clinicians classify seizures by finding familiar patterns in the signs and 




and magnetic resonance imaging (MRIs) (Fisher, Cross, D’Souza, et al., 2017). Due to the 
lack of fundamental knowledge of seizures, it is difficult to classify seizures based on their 
pathophysiology; however, seizures may be classified in many ways, such as by the 
anatomic structures involved (e.g., frontal/temporal), the networks involved (e.g., 
neocortical, limbic), or the observable or treatment-related aspects of the seizures (e.g., 
behavioral semiology, EEG pattern, response to medication) (Fisher, Cross, D’Souza, et 
al., 2017). The ILAE provides a framework for understanding the classification of epilepsy 
by providing a multi-level classification system that involves classification of seizure type, 
epilepsy type, and syndrome, as well as identification of the etiology (see Figure 1) 
(Scheffer et al., 2017).  
 
Figure 1: Classification of epilepsy. This figure illustrates the various levels of 
classification of epilepsy based on the ILAE framework. This figure is 




The ILAE developed an operational system of classification of seizure type for use 
by clinicians that classifies seizures by location of onset and the signs and symptoms of the 
seizure (Fisher, Cross, D’Souza, et al., 2017). The next level of classification is for epilepsy 
type, which can include multiple seizure types.  Epilepsy can also be classified based on 
the syndrome, which is defined as a cluster of features that occur together (Scheffer et al., 
2017). The method of seizure classification utilized is dependent on the ultimate goal of 
classification. For the purposes of this dissertation, classification by seizure type and 
syndrome will be defined. 
Seizure Type. According to the ILAE, classification by seizure type is a “useful 
grouping of seizure characteristics for purposes of communication” (Fisher, Cross, French, 
et al., 2017). The first step in classification of seizure type is to define the type of seizure 
onset (Fisher, Cross, D’Souza, et al., 2017). Focal and generalized seizures are the two 
main types of seizure onset, but seizure onset may also be unknown (Fisher, Cross, 
D’Souza, et al., 2017). Seizures are then classified based on whether they lead to a loss of 
awareness. Finally, seizures are classified based on the most prominent aspect of the 
seizure (Fisher, Cross, D’Souza, et al., 2017). The ILAE recommends that clinicians also 
provide additional descriptors that include sensations, emotions, and cognitions 
experienced during the seizure, movements of specific body parts, and laterality (Fisher, 






Figure 2: Classification of seizure type. This figure illustrates the most recent ILAE 
guidelines for classification of seizure type. This figure is adapted from 
Fisher, Cross, D’Souza, et al. (2017). 
Seizures with a focal onset occur within one hemisphere; the onset can be 
subcortical, localized, or widely distributed (Fisher, Cross, D’Souza, et al., 2017). Focal 
seizures are then classified based on whether the individual is aware during the seizure 
(Fisher, Cross, D’Souza, et al., 2017). Focal seizures can be further characterized by the 
“first prominent sign or symptom” of the seizure, which can be motor (e.g., jerking, loss 




Generalized seizures originate in a network of neurons that span bilaterally 
(Institute of Medicine, 2012). Generalized seizures are further characterized based on 
whether they are motor or nonmotor. Nonmotor generalized seizures are also known as 
absence seizures, which “present with a sudden cessation of activity and awareness” 
(Fisher, Cross, D’Souza, et al., 2017). 
Syndromes. An epilepsy syndrome is “a complex of clinical features, signs, and 
symptoms that together define a distinctive, recognizable clinical disorder” (Berg et al., 
2010). Epilepsy syndromes are characterized by typical age of onset, EEG findings, seizure 
types, and imaging features (Institute of Medicine, 2012; Scheffer et al., 2017). 
Classification by epilepsy syndrome provides information for medical treatment planning 
as well as prognosis.  
 Treatment of epilepsy. A variety of treatments and therapies are available to treat 
epilepsy, including medication, vagus nerve stimulation, surgery, and diet.  
 Medication. Anti-epileptic drugs (AEDs) are the initial treatment of choice for 
children with epilepsy; AEDs work through a variety of mechanisms (e.g., enhancing 
inhibitory neurotransmission or suppressing neuronal excitability) to prevent epileptic 
seizures (Ortinski & Meador, 2004; Schmitz, 2002). If a child is taking one medication it 
is considered monotherapy; approximately 46-61% of children achieve seizure freedom 
after receiving the appropriate medication (Arts et al., 2004; C. S. Camfield, Camfield, 
Gordon, & Dooley, 1997). Polytherapy, which is the use of more than one AED, may be 




2003). Approximately 42% of children who receive a second AED achieve seizure freedom 
(Arts et al., 2004; C. S. Camfield et al., 1997). Generally, children remain on medication 
for two years, with a gradual withdrawal of medication; 70% of children remain seizure-
free after medication withdrawal (Bergin, 2003).  
When an individual’s seizures cannot be controlled with medication, the epilepsy 
is defined as intractable (also described as refractory, drug resistant, or pharmacoresistant) 
(Kwan et al., 2010). An ILAE task force defined intractable epilepsy across two levels. 
Level 1 criteria determine whether the intervention leads to seizure freedom as well as 
whether there are adverse effects of the treatment (Kwan et al., 2010). The Level 2 
definition of intractable epilepsy is “failure of adequate trials of two tolerated and 
appropriately chosen and used AED schedules (whether as monotherapies or in 
combination) to achieve seizure freedom” (Kwan et al., 2010). A number of definitions 
have been applied to the term intractable epilepsy, leading to variable criteria and different 
results, but approximately 6-10% of children have intractable epilepsy (Arts et al., 2004; 
Berg et al., 2001). When AED therapy is ineffective, neurologists will consider adjunctive 
therapies, such as vagus nerve stimulation (Schmitz, 2002). 
 Vagus nerve stimulation. Vagus nerve stimulation (VNS) is a treatment that uses 
an implanted device to send electrical signals to the brain through the vagus nerve and can 
be used in individuals over the age of twelve (Andrews, 2010). VNS can reduce the 
frequency of seizures by about 50% in individuals with intractable epilepsy who are not 




children with a VNS had a reduction in seizures by over 50% and 6.7% were seizure free 
after two years with the implant (Orosz et al., 2014). 
 Surgery. Seizure control can also be achieved through surgical removal of 
epileptogenic brain tissue (Schmitz, 2002). Surgical intervention is generally considered 
after three years of intractable epilepsy and if the patient is a good surgical candidate (e.g., 
localized structural lesion) (Schmitz, 2002). According to a meta-analysis, approximately 
27-66% of patients achieve seizure freedom after epilepsy surgery (Téllez-Zenteno, Dhar, 
& Wiebe, 2005). 
 Other treatments. Other treatment options for epilepsy include diet and behavioral 
treatment. The ketogenic diet is a high fat, low carbohydrate diet that has been effective in 
the treatment of certain epilepsy syndromes and conditions (Kossoff et al., 2009). The 
modified Atkins diet and the low glycemic index treatment are other dietary therapies that 
may also be useful in the treatment of intractable epilepsy (Kossoff et al., 2009). Behavioral 
strategies, such as relaxation, biofeedback, and self-control, have been described in the 
literature, but are poorly researched and limited in their effectiveness (Schmitz, 2002). 
While there are a variety of efficacious treatments for seizures, it is important to note that 
seizures are just one aspect of epilepsy. 
 Outcomes and quality of life in epilepsy. The ILAE Task Force conceptualizes 
epilepsy as “a disorder of the brain characterized by an enduring predisposition to generate 
epileptic seizures, and by the neurobiologic, cognitive, and social consequences of this 




translate to improved quality of life. Epilepsy also impacts cognition, academic 
functioning, psychosocial functioning, and emotional functioning.  “If epilepsy is a disease 
of brain networks and cognition and behavior are the primary functions of those networks, 
then epilepsy may be as much a disorder of cognition and behavior as it is of seizures, with 
cognitive and behavioral symptoms either predating seizures, or vice versa” (Smith, 2016). 
It is important to consider that cognitive, academic, psychosocial, behavioral, and 
emotional difficulties associated with epilepsy may be aspects of the epilepsy itself, rather 
than just comorbidities. 
 Cognitive functioning. Seizures, as well as medications for seizures, affect 
cognitive ability in individuals with epilepsy. Antiepileptic drugs change neuronal activity 
and can lead to cognitive side effects, particularly in individuals on polytherapy (Ortinski 
& Meador, 2004). Common side effects of AEDs include sedation, dizziness, and 
distractibility (Ortinski & Meador, 2004). AEDs also impact neurodevelopment; therefore 
children are at an increased risk for cognitive side effects of these medications (Bergin, 
2003; Ortinski & Meador, 2004; Reuner, Kadish, Doering, Balke, & Schubert-Bast, 2016).  
Epilepsy itself is also a risk factor for cognitive difficulties. In a meta-analysis of 
cognitive functioning in idiopathic generalized epilepsy (IGE), researchers found that 
individuals with IGE had significantly lower scores across all cognitive domains, except 
for visual-spatial abilities, when compared to healthy controls (Loughman, Bowden, & 
D’Souza, 2014). Loughman and colleagues (2014) also found that approximately 25% of 




Children with epilepsy are at considerable risk for cognitive difficulties because 
their brains are still developing (Institute of Medicine, 2012). Reuner et al. (2016) found 
that children with new-onset epilepsy had impaired cognitive performance compared to 
healthy controls, even before starting medication therapy. Furthermore, they found that 
children with chronic epilepsy had even poorer cognitive performance than children with 
new onset epilepsy.  Several seizure and brain-related factors, such as earlier onset of 
seizures, cerebral lesions, and seizure severity, frequency, type, and duration are related to 
cognitive functioning in individuals with epilepsy (Ortinski & Meador, 2004). Seizure 
control and cognitive functioning are important outcomes to consider because chronic 
intractable epilepsy and low intelligence are risk factors for poor psychosocial functioning 
in individuals with epilepsy (Geerlings et al., 2015).  
Psychosocial functioning. Children with epilepsy are at greater risk for negative 
psychosocial outcomes compared to children without seizures. Epilepsy may affect the 
ability to function independently and participate in social activities (Institute of Medicine, 
2012). Adolescents may be particularly affected because epilepsy is associated with a loss 
of independence and individuals with epilepsy are unable to drive. In a report from the 
National Survey of Children’s Health, researchers found that children with epilepsy were 
more likely to have low social competence, school problems, and limited activity when 
compared to children who were not diagnosed with epilepsy (Russ et al., 2012). Epilepsy 
also has psychosocial consequences that extend into adulthood. In a study of adults with 




marital status, learning achievement, and independence (Shackleton, Kasteleijn-Nolst 
Trenite, de Craen, Vandenbroucke, & Westendorp, 2003). Individuals with epilepsy might 
also experience difficulty with interpersonal relationships due to their experiences of 
perceived stigma (McCagh, Fisk, & Baker, 2009). 
Epilepsy can cause psychosocial difficulties for the whole family of an individual 
with epilepsy; this includes stress, restriction of activities, and stigmatization (Ellis et al., 
2000). In a study of 138 young adults with epilepsy, researchers found that poor family 
support was a strong predictor of poor psychosocial outcomes (Geerlings et al., 2015). It is 
important to understand and address family and psychosocial functioning to improve 
quality of life in individuals with epilepsy. 
Stigma. Individuals with epilepsy are at an increased risk of feeling stigmatized and 
discriminated against because of their epilepsy (Baker, Brooks, Buck, & Jacoby, 2000). 
Stigma is the experience of feeling discredited because an individual is different or 
undesirable to others in society (Goffman, 1968). Stigma can be experienced internally 
(e.g., feelings, thoughts, and beliefs about the self), interpersonally (e.g., interactions with 
others), and institutionally (e.g., differential treatment in society) (Muhlbauer, 2002). 
Health-related stigma can be defined as “a social process or related personal experience 
characterized by exclusion, rejection, blame, or devaluation that results from experience or 
reasonable anticipation of an adverse social judgment about a person or group identified 
with a particular health problem” (Weiss & Ramakrishna, 2006). Theoretical models of 




(e.g., salience over time), disruptiveness, aesthetics (e.g., unattractiveness), origin 
(congenital, accidental, or intentional), and peril (e.g., danger to others) (E. E. Jones, 1984). 
Youth with epilepsy are particularly vulnerable to internalized perceptions of stigma. In a 
study of 174 youth with epilepsy, researchers found that child perceptions of stigma were 
related to greater need for information and support, greater child fear and worry about 
seizures, more severe seizures, and younger age (Austin, Perkins, & Dunn, 2014). 
Psychopathology. Youth with epilepsy are at increased risk for anxiety, depression, 
attention-deficit/hyperactivity disorder, and autism when compared to healthy controls and 
other youth with chronic illness (Austin et al., 2011; Caplan et al., 2005; Dunn et al., 2009; 
Reilly et al., 2013). In a large population-based study, neurodevelopmental spectrum 
disorders, including developmental delays, language problems, dyslexia, learning 
disorders, and autism spectrum disorder were found in 41.7% of children with epilepsy 
(Berg, Caplan, & Hesdorffer, 2011). In another population-based study, 21% of children 
with epilepsy met criteria for autism (Reilly et al., 2014). Reilly and colleagues (2014) 
found that 33% of children with epilepsy met criteria for ADHD. Children with epilepsy 
are also reported to have more behavior problems than their siblings (11.3% compared to 
4.6%) (Austin et al., 2011).  
Rates of anxiety and depression are also elevated in children with epilepsy, with 
prevalence in population-based studies ranging from 5% to 24% in anxiety and 7% to 
13.4% in depression (Berg et al., 2011; McDermott, Mani, & Krishnawami, 1995; Reilly 




reported internalizing problems when comparing children with epilepsy and normative 
controls (Rodenburg, Stams, Meijer, Aldenkamp, & Dekovic, 2005). In a population study 
of over 10,000 children, which included 67 children with epilepsy and 47 children with 
diabetes, researchers found that the rate of “emotional” psychiatric disorders in individuals 
with epilepsy was about 16%, compared to 6.4% in children with diabetes and 4.2% in the 
control group (Davies et al., 2003).  
A bidirectional relationship may exist between mood/anxiety disorders and 
epilepsy (Kanner, 2009). Jones et al. (2007) found that forty-five percent of children with 
idiopathic epilepsy had an onset of a psychiatric disorder prior to their first seizure. 
Additionally, the higher prevalence of psychopathology and cognitive and linguistic 
impairments in children with epilepsy suggests that there is a common underlying 
neuropathology (Austin & Caplan, 2007). Berg and colleagues (2011) demonstrated that 
individuals with “complicated” epilepsy have more neurodevelopmental and psychiatric 
disorders than those with uncomplicated epilepsy. High seizure frequency, poor seizure 
control, and polytherapy are all associated with greater risk for psychopathology in 
pediatric epilepsy (Reilly et al., 2013). Other seizure variables, including seizure type, age 
of onset, and duration, are not consistently associated with psychopathology (Reilly et al., 
2013). While factors related to epilepsy are associated with higher levels of psychiatric 
problems in children and adolescents with epilepsy, psychosocial factors may also affect 
psychopathology in children with epilepsy (Caplan et al., 2004; Dunn & Austin, 2004). 




of youth with epilepsy and mental health conditions are diagnosed (Reilly et al., 2014), and 
only 33% of youth with epilepsy with affective and anxiety disorders actually receive 
mental health treatment (Caplan et al., 2005). 
Quality of life. While seizure control is important, the focus of research in epilepsy 
has shifted to consider implications for quality of life. Quality of life is an “individuals’ 
perceptions of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards, and concerns” (“WHO | 
WHOQOL,” n.d.). In a study that examined the trajectories of health-related quality of life 
in 120 children with newly diagnosed epilepsy, Loiselle and colleagues (2016) found that 
42% of children were at risk for low quality of life. Several variables have been associated 
with quality of life in youth with epilepsy, including seizure related variables (number of 
AEDs, AED side effects, seizure frequency), cognitive impairment, internalizing 
symptoms, socioeconomic status, and family functioning (Conway et al., 2016; Loiselle, 
Ramsey, Rausch, & Modi, 2016; Reilly, Atkinson, Das, et al., 2015b).  
Anxiety 
 Anxiety is the most common mental health disorder that affects children and 
adolescents (Rockhill et al., 2010). Anxiety is the emotional reaction precipitating from the 
anticipation of a real or imagined threat to the self or others (Fonseca & Perrin, 2011). It is 
a “future-oriented emotion, characterized by perceptions of uncontrollability and 
unpredictability over potentially aversive events and a rapid shift in attention to the focus 




2002). While fear and anxiety of certain situations are normative and developmentally 
appropriate, anxiety disorders are characterized by fear that is excessive or persistent 
beyond a developmentally appropriate time period (American Psychiatric Association 
[APA], 2013).  
Lang (1968) described three main components to anxiety: a motor response, a 
subjective/cognitive response, and a physiological response. The motor response is 
characterized by behaviors, such as restlessness, immobility, and distress, activated to 
avoid or escape the anxiety provoking stimulus (Lang, 1968). Worries and fearful 
anticipation characterize the cognitive response to anxiety, while the physiological 
response to anxiety consists of the somatic symptoms associated with high autonomic 
arousal, such as increased heart rate and sweating (Lang, 1968).  
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V) reflects this 
three-part model of anxiety in its definitions of the various anxiety disorders (American 
Psychiatric Association [APA], 2013). There are several different types of anxiety 
disorders that can be distinguished from each other by the cognitive ideations (thoughts 
and beliefs) as well as the situations or objects that are feared or avoided (APA, 2013). 
Children with separation anxiety have fears or worries that something harmful will happen 
to attachment figures or something will happen that will separate them from an attachment 
figure (APA, 2013). Youth with separation anxiety are typically “clingy” and may cry or 
become upset when separated from an attachment figure, be reluctant or refuse to go to 




separated from attachment figures, or have nightmares about separation (Vasey, Bosmans, 
& Ollendick, 2014).  Children with selective mutism may have a fear of and avoid speaking 
in certain situations where it is expected (e.g., in school), but are capable of talking in other 
situations (e.g., around family) (APA, 2013). Specific phobias are characterized by fear of 
certain, specific things, such as animals, blood, or other things in the environment. Children 
with specific phobias may cry, freeze up, or cling to an attachment figure when near these 
feared objects or situations (APA, 2013).  Individuals with social anxiety have a fear of 
embarrassing themselves or being judged by others and avoid social interactions and social 
situations (APA, 2013). Panic disorder is characterized by a worry about having panic 
attacks, which consist of feelings of intense fear or discomfort that are associated with 
somatic symptoms and catastrophic thoughts (APA, 2013; Vasey et al., 2014). 
Agoraphobia is defined as a fear of the inability to escape from certain public 
environments, such as in a crowd (APA, 2013). Individuals with generalized anxiety have 
persistent, excessive, and uncontrollable worry about many different types of things, such 
as performance or perfectionism, and they typically have physical symptoms that 
accompany this worry such as restlessness, muscle tension, concentration problems, and 
difficulty sleeping (APA, 2013; Vasey et al., 2014). 
 Childhood through adolescence is considered a key risk period for the first 
symptoms of anxiety (Beesdo-Baum & Knappe, 2012). During development, many 
different types of fears and anxieties are typical and it can be challenging to distinguish 




(Beesdo-Baum & Knappe, 2012). The fears of children evolve as they develop; typical 
fears of early childhood are characterized by concrete and immediate threats and, as 
children get older, fears evolve to anticipatory and more abstract or imagined fears 
(Beesdo-Baum & Knappe, 2012).  An anxiety disorder may develop when anxiety 
symptoms persist, are more intense than expected for a child’s development or out of 
proportion from the threat posed, and cause impairments in important areas functioning, 
such as school or social functioning (Craske & Stein, 2016).  
Prevalence. Anxiety is the most prevalent mental health disorder and affects one 
in nine people worldwide (Craske & Stein, 2016). Estimates of the prevalence of anxiety 
in children vary due to multiple factors, including age groups included, assessment 
instruments, informant, and diagnostic categories used (Beesdo-Baum & Knappe, 2012). 
Despite this difficulty, a recent meta-analysis estimates a world-wide prevalence rate of 
anxiety in children and adolescents of 6.5%, affecting approximately 117 million youth 
(Polanczyk, Salum, Sugaya, Caye, & Rohde, 2015). Prevalence rates in an additional meta-
analysis suggests a prevalence of 10.2% (Costello, Egger, & Angold, 2005). Lifetime 
prevalence rates of anxiety are as high as 31.9% (Merikangas et al., 2010). The economic 
burden of anxiety was estimated to be approximately $43 billion annually in the United 
States in the 1990s; this includes costs associated with treatment, loss of productivity, and 
mortality (Greenberg et al., 1999). 
Diagnosis. Anxiety is typically diagnosed in children through diagnostic interviews 




as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), to determine 
whether children meet certain criteria for a diagnosis. Semi-structured interviews provide 
in-depth insight regarding the specific types of anxiety the child is experiencing and are 
helpful with treatment planning. Clinical judgment is needed to determine the interference 
of the anxiety, which consists of determining the severity, frequency, persistence, and 
impairment of functioning (Craske & Stein, 2016). Diagnostic interviews can be time 
consuming and difficult to use to identify children at risk for anxiety. Furthermore, while 
diagnostic criteria are useful for clinicians working to treat anxiety in youth, Craske and 
Stein (2016) emphasize that anxiety is a dimensional construct. 
Rating scales can be administered to different informants (such as parents, teachers, 
or the child) to quantify the amount, degree, or magnitude of anxiety symptoms (Silverman 
& Ollendick, 2005). Rating scales are useful in assessing and screening for anxiety in youth 
and are frequently utilized in research to identify and quantify features of anxiety 
(Silverman & Ollendick, 2005). Such scales are especially useful to identify maintaining 
variables for anxiety, as well as mediators and moderators for features of anxiety 
(Silverman & Ollendick, 2005). Despite the ease of use and utility of rating scales, social-
desirability may lead to under-reporting of anxiety-symptoms on self-reported rating scales 
(Silverman & Ollendick, 2005). Additionally, it is important to note that rating scales 
represent a somewhat arbitrary metric, and could lead to false positives and/or false 
negatives (Silverman & Ollendick, 2005). Despite some of these challenges regarding the 




symptoms along a continuum allows researchers to identify degrees of disturbance and 
patterns of manifestations without categorizing children or presuming an underlying 
disease. 
Risk and protective factors. Risk factors are defined as variables that influence, 
intensify, precipitate, maintain, or predispose to maladaptation or psychopathology (Vasey 
& Dadds, 2000). Complementary to this concept, protective factors “serve to protect 
against the development of childhood anxiety disorders or to foster a return to a normal 
developmental pathway subsequent to their onset” (p. 7, Vasey & Dadds, 2000). It is 
important to note that risk and protective factors can be enduring or transient, they are not 
merely additive but influence each other, and they may contribute to other 
psychopathologies. Vasey and Dadds (2000) outline a variety of predisposing factors that 
influence anxiety, including: genetics, neurobiology, temperament, emotion regulation, 
cognitive biases and distortions, parental responses, experiences with conditioned stimuli, 
and level of exposure to stimuli. Below is a brief summary of the various risk and protective 
factors that serve to maintain or ameliorate symptoms of anxiety. 
 Genetic influences. A genetic predisposition for anxiety is clear throughout the 
literature. Children of parents with anxiety are almost four times more likely to have 
anxiety than children of parents without anxiety (Micco et al., 2009). The genetic aspects 
of anxiety are elucidated through several avenues of research, including twin studies, 




Several genes have been implicated in the expression of anxiety. Studies examining 
epigenetics highlight the importance of environmental factors on gene expression. 
 Studies of monozygotic and dizygotic twins provide information about how genes 
can influence anxiety because they parcel anxiety into three factors: additive genetic 
influences (e.g., gene alleles), shared environmental influences (e.g., parenting), and 
unshared environmental influences (Gregory & Eley, 2011). Heritability estimates for 
anxiety disorders are in the range of 30-40% (Hettema, Neale, & Kendler, 2001). Genetic 
influences also account for anxious behaviors, including behavioral inhibition, shyness, 
emotional dysregulation, and neuroticism (Barzman, Geise, & Lin, 2015; Battaglia et al., 
2017; Bienvenu, Hettema, Neale, Prescott, & Kendler, 2007; Johnson, Carver, Joormann, 
& Cuccaro, 2016). 
 Several genes have been implicated in the expression of anxiety, many of which 
are associated with neurotransmitter systems. The serotonin transporter polymorphism (5-
HHLPR) can vary in the number of repeated sections of DNA, and both longer and shorter 
alleles have been implicated in higher anxiety personality symptoms (Schinka, Busch, & 
Robichaux-Keene, 2004).  Anxiety is linked to DNA changes that affect catechol-O-
methyltransferase, an enzyme that is important for both serotonin and dopamine pathways, 
and the GAD1 gene, which synthesizes GABA from glutamate (Hettema et al., 2006; 
McGrath et al., 2004). Finally, genes for the corticotrophin-releasing hormone, which is 




Epigenetic changes are the alterations made in the chemical and physical structure 
of DNA induced by environmental factors (Higley, 2016). Epigenetics can elucidate how 
the environment affects gene expression. For example, in a study of rats, maternal care 
(e.g., licking and grooming) produces methylation of a glucocorticoid receptor promotor 
in the hippocampus associated with the stress response (Champagne et al., 2006). This 
provides evidence that biological changes may be induced by environmental factors. There 
are many genetic influences of anxiety, but studies reviewing epigenetics and aspects of 
gene expression further complicate our understanding about the heritability of anxiety and 
lay the groundwork for the importance of environmental factors. It is likely that genetic 
factors predispose children to a “vulnerability” for anxiety (Barlow, 2002). 
 Neurobiological influences. Neurobiological factors have been assessed to 
understand the development of anxiety in children. Many neurobiological influences, 
including brain structures, such as the amygdala, and neurotransmitter/endocrine systems 
have been associated with anxiety. The amygdala has been at the forefront of research on 
brain regions involved in fear and anxiety. It is an important component of the limbic 
system, which is involved in processing emotional experiences (Cummins & Ninan, 2002). 
Hyperactivation of the amygdala and insula was found in a meta-analysis of imaging 
studies of PTSD, social anxiety, and specific phobia; this hyperactivation was also found 
in healthy subjects undergoing fear conditioning (Etkin & Wager, 2007). In other fear 
conditioning paradigms, expression of the fear response has been associated with the dorsal 




extinction of these responses has been associated with the ventral ACC/mPFC (Etkin, 
Egner, & Kalisch, 2011). Etkin (2012) suggests that the ACC/mPFC are dysfunctional in 
individuals with anxiety. 
 Multiple endocrine systems and neurotransmitters have been implicated in anxiety; 
the neurotransmitters and systems involved may vary based on the anxiety disorder 
experienced. GABA, which is an inhibitory neurotransmitter, has been associated with 
stress and anxiety (Kalueff & Nutt, 2007). Individuals with GAD have reduced GABA-A 
receptor density and GABA-A agonists reduce symptoms of anxiety (Kalueff & Nutt, 
2007; Martin, Ressler, Binder, & Nemeroff, 2009). Serotonin has also been implicated in 
anxiety, and some studies have determined that there is decreased 5HIAA CSF 
concentration in anxiety (Martin et al., 2009). The serotonin transporter is a protein that 
moves serotonin from the synaptic cleft to the presynaptic neuron and higher density has 
been correlated with more anxiety symptoms in GAD (Lesch et al., 1996; Martin et al., 
2009). 5HT1A has been shown to increase anxiety at hippocampal postsynaptic receptors 
and decrease anxiety at dorsal raphe nucleus autoreceptors (Martin et al., 2009). Finally, 
the 5HT2 neurotransmitters increase anxiety symptoms and 5HT2 antagonists reduce 
anxiety symptoms (Martin et al., 2009; Vaswani, Linda, & Ramesh, 2003). 
Temperament. Temperament is the socioemotional behavior seen in early 
development that shapes a child’s mood and behavior in certain contexts (Pérez-Edgar & 
Fox, 2005). Behavioral inhibition, negative affect, harm avoidance, and novelty seeking 




Fox, 2005). Temperament is thought to affect anxiety in four ways. First, in conjunction 
with the diathesis-stress model, temperament may interact with environmental stressors to 
predispose youth to anxiety (Vasey et al., 2014). The pathoplasticity model suggests that a 
child’s temperament may also affect how parents or others interact with them, which 
shapes their environment (Vasey et al., 2014). Next, changes in temperament may be a 
product of the development of the anxiety disorder, which is known as the complication or 
scar model (Vasey et al., 2014). Finally, the continuity model suggests that temperament 
and anxiety have the same underlying processes and reflect the same construct (Vasey et 
al., 2014). 
 Behavioral inhibition is the tendency to be shy and cautious, which is a 
temperament that has been associated with anxiety (Hirshfeld et al., 1992; Kagan, Reznick, 
& Snidman, 1987; Kagan & Snidman, 1999). Children with behavioral inhibition are likely 
to be highly reactive to unfamiliar situations, which constrains the probability that the child 
will be uninhibited in his or her behavior (Kagan & Snidman, 1999). Behaviorally inhibited 
children have more physiological reactions to anxiety (e.g., increased heart rate, higher 
cortisol) and are more likely to experience anxiety (Hirshfeld et al., 1992; Kagan & 
Snidman, 1999). Having a behaviorally inhibited temperament is associated with 
physiological aspects of anxiety and shapes avoidance behavior of anxiety provoking 
environments.  
Negative affect is characterized by the experience of negative emotions, high 




& Hooe, 2003). Negative affect is a component of the tripartite model of anxiety and 
depression, and high levels of negative affect are associated with anxiety in adolescents 
(Lonigan et al., 2003). In a meta-analysis of studies examining temperament in panic 
disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD), researchers 
found that harm avoidance was positively associated with symptoms of all three diagnoses 
and there was a marginal negative relationship between novelty seeking and social anxiety 
and OCD (Kampman, Viikki, Järventausta, & Leinonen, 2014). It is important to note that 
while temperament has been associated with the development of anxiety, a child is both 
the producer of and a product of their environment because children develop through a 
reciprocal interaction with the environment (Pérez-Edgar & Fox, 2005). 
Gender. Women are more likely than men to be diagnosed with an anxiety disorder; 
by the age of six, girls are two times more likely to have experienced anxiety (Costello et 
al., 2005; Craske & Stein, 2016; Lewinsohn, Gotlib, Lewinsohn, Seeley, & Allen, 1998). 
In a large sample of adults, researchers found that not only was anxiety more prevalent in 
women, but it was also more disabling and resulted in greater illness burden (McLean, 
Asnaani, Litz, & Hofmann, 2011). Despite the greater prevalence of anxiety in women and 
girls, it is still unclear why they are at greater risk for anxiety (Costello et al., 2005; Craske 
& Stein, 2016). When adjusted for potentially cofounding factors, anxiety is still more 
prevalent in girls (Lewinsohn et al., 1998). 
Cognition, control, and learning. Information processing biases, composed of 




with anxiety (Muris & Field, 2008). These cognitive distortions can be explained by the 
cognitive-behavioral theory of child psychopathology that suggests that anxiety results 
from schemas regarding danger and vulnerability that lead children to focus on threatening 
information and ultimately develop maladaptive thought patterns that maintain anxiety 
(Kendall, 1985). While anxiety and cognitions are inter-related, it is important to note that 
this does not necessarily imply a causal relationship; additionally, both environmental 
factors, such as learning, and genetic factors play a role in the development of cognitive 
distortions (Muris & Field, 2008). 
Attention bias is the tendency to be hyper-attentive towards threatening information  
and is generally measured through Stroop tasks with emotionally laden words and dot-
probe tasks (Muris & Field, 2008). A meta-analysis concluded that anxious children and 
adults demonstrate threat-related biases when compared to healthy controls (Bar-Haim, 
Lamy, Pergamin, Bakermans-Kranenburg, & van IJzendoorn, 2007). Youth with anxiety 
consistently demonstrate interpretation bias, which is the tendency to perceive ambiguous 
situations as threatening (Miers, Blöte, Bögels, & Westenberg, 2008; Muris & Field, 2008; 
Rozenman, Amir, & Weersing, 2014). Finally, a tendency to recall memories congruent 
with anxious cognitions is considered memory bias; however, evidence for this type of bias 
is lacking in studies of youth and adults with anxiety (Muris & Field, 2008). While there 
is evidence that children and adolescents demonstrate information processing biases, it is 




and verbalize cognitive distortions (Cartwright-Hatton, Reynolds, & Wilson, 2011; Muris 
& Field, 2008). 
Researchers suggest that experience with uncontrollable events may predispose a 
child to a psychological vulnerability that leads them to perceive events as outside of their 
control (Chorpita & Barlow, 1998). Chorpita and Barlow (1998) propose that in early 
development, such uncontrollable events lead to a psychological vulnerability that is a 
mediator to anxiety, while later in development, the psychological vulnerability amplifies 
anxiety and acts as a moderator. In a recent meta-analysis, researchers found a mean effect 
size of -.524 between perceived control and anxiety; this relationship was stronger in adults 
than children (Gallagher, Bentley, & Barlow, 2014). 
 Learning also plays a key role in the development of anxiety. Rachman (1977, 
1991) proposed three pathways for the acquisition of fear: conditioning, modeling or 
vicarious learning, and verbal acquisition.  In other words, children may acquire fear 
through direct experiences, through observation of the reactions of others, through verbal 
information, or through a combination of all three (Field & Purkis, 2011).  
Family factors. Environmental factors play an important role in the development 
of anxiety, and parents have become a large focus of research examining environmental 
risk and protective factors for anxiety (Creswell et al., 2011; Gregory & Eley, 2007). 
Murray et al. (2009) describes three pathways in which parents can influence the 
development of anxiety. First, parents may socialize their child in a way that leads the child 




Next, a child may learn anxiety from an anxious parent who models or verbally mediates 
anxiety (Murray et al., 2009). Finally, Murray and colleagues (2009) suggest that parents 
may respond to a child’s anxiety in ways that maintain or intensify anxiety (e.g., 
accommodation and avoidance of anxiety provoking situations). Several parenting factors 
likely play a role in the development of child anxiety, including parental beliefs, parenting 
styles, and parenting behaviors. 
While some aspects of the intergenerational transmission of anxiety may be due to 
genetic factors, it is also likely that parental anxiety leads to certain environmental factors 
that make children more vulnerable to anxiety. One potential mediator of parent and child 
anxiety is parental beliefs. In a study of 103 youth with anxiety, researchers found that 
parental beliefs about anxiety mediated the relationship between parent and child anxiety 
(Francis & Chorpita, 2011). Parenting styles have also been examined. Craske (1999) 
suggested that while parenting styles may activate trait anxiety, parenting behaviors may 
lead to the development of an anxiety disorder. 
 Parental control, characterized by over-involvement in activities, routines, or 
emotional experience, has also been examined as a factor in child anxiety. Parental control 
may act by reducing a child’s sense of control of the environment, which can lead to anxiety 
(Barlow, 2000; Becker, Ginsburg, Domingues, & Tein, 2010; Chorpita, Brown, & Barlow, 
1998). In a meta-analysis of parenting and child anxiety, researchers found that child 
anxiety was more strongly associated with parental control than with parental rejection; 




Wood, & Weisz, 2007). McLeod and colleagues (2007) found that parenting accounted for 
about 4% of the variance in child anxiety, which suggests that while parenting and family 
factors play a role in the development of anxiety, they likely interact with other factors, 
such as the child’s age, biological vulnerability, and other life events (Creswell et al., 2011; 
Murray et al., 2009). 
Developmental psychopathology model of anxiety. The developmental 
psychopathology model of anxiety posits the concept of multideterminism: there are a wide 
range of causal influences for the development of anxiety that are complex, dynamic, and 
interact with each other (Vasey & Dadds, 2000). Vasey and Dadds (2000) suggest that the 
risk and protective factors for anxiety interact and influence each other in a transactional 
manner. They also present the concepts of multifinality and equifinality. Multifinality 
posits that any risk or protective factor can lead to multiple outcomes; for example 
childhood maltreatment, punishment, parental psychopathology, low socioeconomic 
status, and harsh parenting are non-specific risk factors for all mental health disorders 
(Craske & Stein, 2016). Complimentary to this concept is that of equifinality, which states 
that there are multiple pathways to the same outcome (Vasey & Dadds, 2000). 
Vasey and Dadds (2000) propose an integrative model of developmental 
psychopathology that suggests that cumulative risk for anxiety is created from a balance of 
the transactional influences of risk and protective factors. They also suggest that there are 
two pathways to anxiety: one in which there are clear precipitating events (e.g., 




gradually intensify over time (Vasey & Dadds, 2000). In addition to the risk and protective 
factors that influence the development of anxiety, Vasey and Dadds (2000) also highlight 
factors that contribute to the maintenance and intensification of anxiety. These factors 
include: avoidance, incompetence across different skill domains (e.g. academic, emotion-
regulation, social), cognitive biases and distortions, punishment and failure, and responses 
by others that influence avoidance (e.g., overprotection) (Vasey & Dadds, 2000). They 
propose that temperament and developmental status can alter the degree to which these 
factors influence anxiety (Vasey & Dadds, 2000). Additionally, Vasey and Dadds (2000) 
suggest that “desistance” of anxiety can be promoted through opposite and complimentary 
factors (e.g., exposure, cognitive restructuring). 
 Treatment of anxiety. Anxiety disorders in children are commonly treated through 
therapy and medication. Cognitive behavioral therapy (CBT) is an effective treatment for 
anxiety disorders in youth that generally includes psychoeducation, cognitive restructuring, 
coping skills training, and graduated exposures (Compton et al., 2010). In a review of 
treatments for youth with anxiety, well-established treatments with strong empirical 
support included CBT with exposure, exposure-only, modeling, CBT with parents, and 
CBT with medication (Higa-McMillan, Francis, Rith-Najarian, & Chorpita, 2016). 
Common practice elements that are aspects of the most well-established treatments include: 
exposure (87.9%), cognitive techniques (53.9%), relaxation (53.9%), psychoeducation 




exposure-based approaches had larger effect sizes, more durability, and more current 
support in the literature (Higa-McMillan et al., 2016).  
Selective serotonin-reuptake inhibitors (SSRIs) are the most common medications 
prescribed to treat anxiety in youth; however, there is still limited research regarding the 
safety and durability of these medications in children (Compton et al., 2010). Walkup and 
colleagues (2008) compared treatment with CBT alone, sertraline alone, a combination of 
sertraline and CBT, and placebo in a large multicenter randomized study of 488 children 
and adolescents between the ages of 7 and 17. Researchers found that combination therapy 
of sertraline and CBT led to the most improvement in anxiety symptoms, with 80.7% of 
children on combination treatment being very much or much improved, compared to 59.7% 
with CBT alone, 54.9% with sertraline alone, and 23.7% with placebo (Walkup et al., 
2008). These findings suggest that SSRIs and CBT are effective treatments, but a 
combination of medication and therapy leads to the most improvement in anxiety 
symptoms. 
 Quality of life in anxiety. Anxiety has significant effects on an individual’s quality 
of life. Childhood anxiety not only predicts anxiety in adolescence and adulthood, but 
anxiety can also be a predictor of other mental health problems in adulthood (Rapee, 
Schniering, & Hudson, 2009). In a meta-analysis of 23 studies, researchers found that 
individuals with anxiety had overall poorer quality of life than control subjects (Olatunji et 
al., 2007). Additionally, individuals with anxiety are particularly affected across the mental 




with a variety of psychopathology, researchers found that children with anxiety were most 
affected in the emotional domain of quality of life (Bastiaansen, Koot, Ferdinand, & 
Verhulst, 2004). Effective treatment of anxiety with medication is associated with 
improvements in quality of life and greater anxiety symptom reduction is associated with 
better improvement in quality of life (Hofmann, Wu, Boettcher, & Sturm, 2014). Treatment 
with cognitive behavioral therapy is also associated with moderate improvements in quality 
of life, particularly in the physical and psychological domains (Hofmann, Wu, & Boettcher, 
2014).  
Anxiety in Pediatric Epilepsy 
The forgotten disorder. The prevalence of anxiety in individuals with epilepsy 
appears to be elevated compared to rates of anxiety in the general population (Scott, 
Sharpe, Hunt, & Gandy, 2017). This higher prevalence may be driven by both biological 
and psychosocial factors. Many researchers have suggested that there is a bidirectional 
relationship between anxiety and epilepsy, which can be driven by the biological correlates 
of anxiety and epilepsy (Adelöw et al., 2012; Kanner, 2009). Additionally, there are 
multiple psychosocial impacts of epilepsy that may lead to worry, including the impact of 
epilepsy on independence, school functioning, and relationships (Scott et al., 2017). 
Despite these biological, psychosocial, and environmental risk factors for anxiety in 
individuals with epilepsy, anxiety is still considered the “forgotten” disorder and has been, 
until more recently, widely ignored in the epilepsy research (Gandy et al., 2015). 




because children with anxiety may not be able to verbalize their feelings and may present 
with disruptive or irritable behaviors (Ettinger et al., 1998). Scott and colleagues (2017) 
emphasize the importance of more research to elucidate the medical and psychosocial risk 
factors of anxiety in epilepsy in order to improve quality of life. 
Prevalence of anxiety in epilepsy. Rates of anxiety in children and adolescents 
with epilepsy range from 5% to 38.5% (Berg et al., 2011; Caplan et al., 2005; J. E. Jones 
et al., 2007; Kwong et al., 2016; Reilly, Atkinson, Chin, et al., 2015; Russ et al., 2012; 
Schraegle & Titus, 2017b, 2017a; Williams et al., 2003). Reasons for the discrepancies in 
rates of anxiety may be related to methodological differences. In a study of 501 children 
with epilepsy recruited from 16 pediatric neurologists in Connecticut, Berg et al. (2011) 
found low rates of anxiety (5%); however, this study relied on parents to indicate whether 
or not their children had a variety of different psychopathologies approximately 9 years 
after epilepsy diagnosis. In contrast, through the use of a diagnostic interview, Jones and 
colleagues (2007) found rates as high as 38.5% in a study that included 53 children with 
recent onset idiopathic epilepsy recruited from two pediatric neurology clinics in 
Wisconsin. In a recent meta-analysis studying prevalence of anxiety and depression in 
adults with epilepsy, Scott and colleagues (2017) found that prevalence rates of anxiety 
varied based on method of diagnosis. Prevalence of anxiety was 8.1% in studies that 
utilized clinician judgement compared to a prevalence rate of 26.9% in studies that utilized 
a structured clinical interview, suggesting that clinicians may underestimate the prevalence 




Anxiety is much more prevalent in children with epilepsy compared to heathy 
children or children with other chronic health conditions (Russ et al., 2012).  In a national 
survey of over 90,000 children, 17% of children with epilepsy/seizure disorders were 
reported by their parents to experience anxiety compared to just 3% of children without 
epilepsy (Russ et al., 2012). Jones and colleagues (2007) compared 53 children with recent 
onset idiopathic epilepsy and 50 healthy controls using a diagnostic interview (KSADS) 
and found that 35.8% of children with epilepsy had anxiety compared to 22% of healthy 
controls. Additionally, they found that 45% of children with epilepsy had an onset of a 
psychiatric diagnosis before their first seizure and one third of these diagnoses were anxiety 
(Jones et al., 2007). In a study of 101 adolescents with epilepsy in Jordan, the odds ratio 
for anxiety was 3.66 when compared to healthy controls (Alwash et al., 2000). In a meta-
analysis of anxiety in children with chronic illness, researchers suggested that children with 
epilepsy are one of the groups with the highest risk for anxiety symptoms and found the 
effect size was significantly elevated (d=.34) (Pinquart & Shen, 2011). While anxiety is 
prevalent in youth with anxiety, relatively few children receive adequate treatment. Caplan 
and colleagues (2015) found that of children with affective or anxiety disorders and suicidal 
ideation, only 33% were receiving mental health services. 
Prevalence of specific anxiety diagnoses. In an MRI study of children with recent-
onset epilepsy, 12.5% had a diagnosis of specific phobia, 9.1% had a diagnosis of 
separation anxiety, 6.8% had a diagnosis of social anxiety, and 5.7% had a diagnosis of 




in adults with epilepsy found the pooled prevalence of generalized anxiety to be 10.2%, 
social phobia was 5.3%, agoraphobia was 2.8%, panic disorder was 2.6%, and specific 
phobia was 1.3% (Scott et al., 2017).  
Risk and protective factors for anxiety in pediatric epilepsy. Pinquart and Shen 
(2011) offer a variety of reasons for why children with a chronic illness may experience 
anxiety, including: confrontation with dangerous stimuli (e.g., seizures), increased fear of 
death, reduced control of the environment, uncertainty of illness and symptoms, risk of 
peer rejection and associated social anxiety, parental over-protectiveness, and illness 
symptoms that are similar to anxiety symptoms. 
The etiology of anxiety in pediatric epilepsy is multifactorial, and likely involves 
psychosocial, biological, and familial factors (Jones et al., 2015). Herman and colleagues 
(1988) suggest a multietiological framework that integrates four hypotheses to understand 
the greater prevalence of psychopathology in epilepsy. First, they suggest that there are 
biological variables that are related to the cause, course, or outcome of the epilepsy that 
also affect psychopathology (Hermann, Whitman, Hughes, Melyn, & Dell, 1988). Second, 
Herman and colleagues (1988) suggest that psychosocial factors, such as stigma, 
discrimination, and loss of social support, create stress that make individuals with epilepsy 
more susceptible to psychopathology. Next, epilepsy medications may provide some risk 
for psychopathology. Finally, demographic variables, such as age, education, sex, and race, 
may be important factors to consider. This multietiological framework continues to be used 




framework has recently been expanded to include family factors, such as parenting, family 
functioning, and parental psychopathology.   
Biological correlates of anxiety in epilepsy. There are several aspects of brain 
dysfunction in epilepsy that may contribute to higher symptoms of anxiety. Depending on 
the location affected, seizures themselves may cause anxiety symptoms in individuals with 
epilepsy. The limbic system, which includes the amygdala and the hippocampus, is a brain 
region that is highly related to both anxiety and epilepsy. Common dysfunction in 
neurotransmitter pathways may also contribute to the higher prevalence of anxiety in 
individuals with epilepsy. Finally, there is emerging evidence that anxiety and epilepsy 
have a bidirectional relationship. 
Seizures. Seizures are defined by four distinct phases: pre-ictal, ictal, post-ictal, and 
inter-ictal. Symptoms of anxiety can occur during any aspect of the seizure experience: 
ictally, postictally, or interictally.  The pre-ictal period is defined as the time immediately 
prior to the seizure. The ictal period, or ictus, is the period of time when the seizure is 
occurring. Anxiety can occur during the ictal period when a person experiences fear during 
a seizure; this can be especially prevalent in individuals with temporal lobe epilepsy when 
a seizure causes amygdala activation (Beyenburg, Mitchell, Schmidt, Elger, & Reuber, 
2005). Seizures that propagate from other limbic structures, such as the orbitofrontal cortex 
or the cingulate gyrus, also can lead to ictal fear (Biraben et al., 2001). The post-ictal period 
is the time immediately after a seizure. Immediately after a seizure, individuals with 




(Beyenburg et al., 2005). The inter-ictal period is the time between seizures. Individuals 
with epilepsy might have symptoms of anxiety during the time between seizures for a 
number of reasons, including: phobia of seizures, problems with adjustment, side effects 
of medication, or surgical consequences (Beyenburg et al., 2005). Anxiety that occurs 
immediately before, during, or after the seizure is generally transitory; anxiety that occurs 
during the inter-ictal period will be the primary focus of this dissertation. 
 Prefrontal cortex. In an MRI study of 44 children with complex partial seizures, 
researchers found significantly smaller inferior frontal white matter volumes in children 
with a psychiatric diagnosis compared to those without (Daley et al., 2007). In a sample of 
88 children with recent-onset epilepsy and 49 healthy controls, Jones and colleagues (2015) 
found that children with epilepsy and anxiety had significantly thinner cortex in the right 
frontal pole, right orbital frontal cortex, and left medial orbital frontal cortex. These studies 
suggest that the prefrontal cortex may develop differently in children with both epilepsy 
and anxiety. 
 Amygdala. The amygdala is at the forefront of research relating epilepsy and 
psychopathology. Emotional symptoms, such as fear and palpitations, may emerge when 
the amygdala is activated during a seizure (Yilmazer-Hanke, O’Loughlin, & McDermott, 
2016). Researchers suggest that the amygdala may also be important to the inter-ictal 
experience of anxiety in epilepsy, particularly in patients with temporal lobe epilepsy 
(Yilmazer-Hanke et al., 2016). In an MRI study of 28 children with cryptogenic epilepsy 




amygdala volumes between the epilepsy and control group, but found that children in the 
CPS group with affective and anxiety disorders had greater asymmetry in the amygdala 
and significantly larger left amygdala volume compared to children without 
psychopathology (Daley et al., 2008).  Jones and colleagues (2015) also found significantly 
larger left amygdala volume in children with epilepsy and anxiety.  In a study of 26 children 
with absence epilepsy, Cohen (2009) found that amygdala volume was not related to an 
affective or anxiety disorder diagnosis and suggested that this may be related to the shorter 
duration of illness in children with epilepsy. Overall, there is some evidence that suggests 
that children with epilepsy are at risk for or may have differences in amygdala volume. 
Neurotransmitters. Serotonin and the 5HT receptors have been consistently 
associated with symptoms of anxiety (Lesch et al., 1996; Martin et al., 2009; Vaswani et 
al., 2003) and research has shown that there are abnormalities in these receptors in 
individuals with temporal lobe epilepsy (Merlet et al., 2004; Savic et al., 2004; Toczek et 
al., 2003).  In a study using PET imaging, individuals with temporal lobe epilepsy had 
reduced serotonin receptor binding in the area of seizure focus (Toczek et al., 2003). Other 
researchers have shown that the regions affected by reduced receptor binding expand to 
areas of the limbic system, including the hippocampus, amygdala, anterior cingulate, 
insula, and raphe nuclei (Savic et al., 2004). Merlet et al. (2004) found that reduced receptor 
binding was greater in the areas of seizure onset as well as in the areas where the seizure 




to reduce symptoms of anxiety by the modulation of calcium ion channels and the 
potentiation of GABAergic inhibition (Mula, Pini, & Cassano, 2007). 
Bidirectional relationship. Many researchers have suggested that there is a complex 
and bidirectional relationship between anxiety and epilepsy (Adelöw et al., 2012; Kanner, 
2009). In a review of seizure incidence in psychopharmacological clinical trials, 
researchers found high rates of seizures in the control condition, suggesting that seizure 
risk may be related to psychopathology (Alper, Schwartz, Kolts, & Khan, 2007). 
Additionally, in a review of hospitalization records, Adelöw and colleagues (2012) found 
a 2.7 odds ratio for an unprovoked seizure in individuals discharged with a diagnosis of 
anxiety. Jones and colleagues (2007) found that 45% of children with epilepsy had a 
psychiatric diagnosis before their first seizure and suggested that antecedent 
neurobiological factors may cause both anxiety and epilepsy. A bidirectional relationship 
between epilepsy and anxiety is supported in research completed with rats with epilepsy 
that exhibited anxious behaviors prior to the onset of seizures (N. C. Jones et al., 2008). 
Cramer, Brandenburg, and Xu (2005) suggest that higher rates of anxiety and depression 
in individuals with temporal-lobe epilepsy are due to common limbic pathways and 
neurotransmitters. Research suggests that while a causal relationship may exist between 
anxiety and seizures, there may also be a common underlying biological vulnerability for 
anxiety and seizures in individuals with epilepsy.  
Seizure variables. Seizure related variables, such as duration of epilepsy, number 




been consistently examined to determine their relationship to child psychopathology and 
anxiety. Results from this research is inconclusive, with some studies indicating that 
seizure and epilepsy related variables contribute to anxiety, while others find other 
environmental factors to be more predictive of anxiety.   
Epilepsy or seizure severity. Several researchers utilized an epilepsy severity 
composite to approximate the impact of multiple seizure related variables. In a study of 
501 children with epilepsy, researchers found that neurodevelopmental and psychiatric 
disorders were more prevalent in individuals with complicated epilepsy (Berg et al., 2011). 
However, in a study of 91 children with epilepsy Rodenburg et al. (2006) found that 
epilepsy factors did not significantly predict internalizing problems. Jones and colleagues 
(2015) echo these findings and determined that seizure severity did not differ significantly 
in children with or without anxiety in youth with recent onset epilepsy. The variability in 
the results regarding epilepsy severity are likely due to differences in how severity is 
defined. 
Duration of epilepsy and age of onset. Findings are also mixed when duration of 
epilepsy is considered. In a comparison of 35 children with epilepsy and 35 healthy 
controls, Oguz and colleagues (2002) found that epilepsy duration was related to higher 
anxiety. Caplan et al. (2008) found that in 69 children with childhood absence epilepsy 
(CAE), children had a 1.35 greater chance of having a psychiatric diagnosis for each year 
of their CAE diagnosis. However, in several other studies, duration of epilepsy was not 




Jones et al., 2015; Rodenburg et al., 2006; Schraegle & Titus, 2017a). Age of onset 
consistently did not predict anxiety symptoms or general mental health in children with 
epilepsy (Buelow et al., 2003; Caplan et al., 2004; Jones et al., 2015; Oguz et al., 2002). 
Discrepancies may exist in the findings due to inadequate sample sizes, differing methods 
of assessment, and the epilepsy types included in analyses. Additionally, duration of 
epilepsy may be confounded by other variables, such as the child’s chronological age and 
age of onset (Austin & Caplan, 2007).     
 Seizure control. Research is inconclusive regarding the relationship between 
seizure control and anxiety. Researchers in Jordan found that psychiatric symptoms were 
higher in adolescents with medically uncontrolled epilepsy (Alwash et al., 2000). Berg and 
colleagues (2011) determined that after adjusting for externalizing behaviors and age, 
having a 5-year remission status was associated with 43% lower prevalence of internalizing 
symptoms. Schraegle and Titus (2017a) found that rates of anxiety were significantly 
higher in youth with intractable epilepsy. However, Caplan and colleagues (2004) found 
that prolonged seizures were not related to anxiety and Ott and colleagues (2001) also 
found that seizure control was not related to psychopathology. The differences in findings 
in the literature are likely attributed to the variety of definitions applied to seizure control 
and the lack of a standardized and consistent terminology for this construct. 
Seizure frequency. Seizure frequency has been consistently related to symptoms of 
anxiety in the literature. In a study of 201 adults with epilepsy, high seizure frequency was 




compared to healthy controls, Oguz et al. (2002) also found that daily seizures were related 
to increased ratings of anxiety. Caplan and colleagues (2007) echo these findings in that 
youth with absence epilepsy with higher seizure frequency were significantly more likely 
to have a psychiatric diagnosis. In a review of differential diagnoses of psychiatric 
disorders in children with epilepsy, Dunn and Austin (2004) emphasized the importance of 
seizure frequency. While most evidence suggests that seizure frequency is related to 
psychopathology in youth with epilepsy, small sample sizes and relatively few studies 
examining anxiety in youth make it difficult to fully understand the role of seizure 
frequency in anxiety symptoms.  
Medication. There are a variety of anti-epileptic medications that can be used to 
treat epilepsy and most studies are not powered to review differences between medications. 
Therefore, most research examining anxiety and AEDs has focused on a comparison of 
monotherapy and polytherapy. Caplan and colleagues (2004) did not find a relationship 
between AED type and anxiety. Additionally, Jones and colleagues (2015) determined that 
the number of AEDs did not differ significantly in children with or without anxiety. 
Alternatively, in a study of 101 children with epilepsy, researchers found that the number 
of AEDs taken was a predictor of anxiety (Williams et al., 2003). Oguz (2002) also found 
that polytherapy was related to higher symptoms of anxiety. Polytherapy was also a risk 
factor for anxiety in adolescents and adults in Nigeria (Adewuya & Ola, 2005; Fatoye, 
Mosaku, Komolafe, & Adewuya, 2006). Interestingly, Schraegle and Titus (2017a) found 




history of psychopathology, but polytherapy did significantly predict anxiety in youth with 
parents who had no history of psychopathology. In a recent review, Reilly and colleagues 
(2013) suggested that increased use of AEDs leads to an increased risk for anxiety in 
children. However, in a recent meta-analysis of adults with epilepsy, Scott and colleagues 
(2017) found that rates of anxiety were not higher in individuals with epilepsy who were 
treated with polytherapy. It is unclear whether the effects of polytherapy would be similar 
for youth and adults due to the confounds of age and length of AED treatment. 
Additionally, it is difficult to distinguish whether higher rates of anxiety in individuals 
taking polytherapy are due to side effects of multiple medications or because polytherapy 
is an indication of more complex and difficult to control seizures, or a combination of these 
factors (Austin & Caplan, 2007). 
Seizure type and focus. Understanding differences in rates of anxiety based on 
seizure type and focus would provide important information regarding the neurobiology of 
anxiety; however, to date, the research is limited. In a study comparing children with 
complex partial seizures and children with childhood absence epilepsy, Caplan and 
colleague (2005) found that there was a higher rate of anxiety in children with absence 
epilepsy. In a study of 48 children with complex partial seizures, 39 children with primary 
generalized epilepsy with absence seizures, and 59 healthy controls, researchers found that 
children with epilepsy had higher rates of psychopathology compared to healthy controls, 
but rates of psychopathology did not differ between the two groups with epilepsy (Ott et 




surgery, researchers found that there was no difference in rates of anxiety in children with 
temporal lobe epilepsy compared to children with other epilepsy types (Salpekar et al., 
2013). Oguz et al., (2002) also did not find a relationship between epilepsy type and 
anxiety. In a study of 501 children with epilepsy, researchers found that specific subtypes 
of epilepsy were not related to specific psychiatric symptoms, which suggests that epilepsy 
has a more broad and general impact on psychopathology (Berg et al., 2011). Overall, while 
the number and quality of studies examining pediatric anxiety in epilepsy are limited, 
tentative findings suggest that rates of anxiety do not differ based on seizure type nor focus 
in children with epilepsy, but more research is needed. 
Summary of seizure related variables. Austin and Caplan (2007) suggest that it is 
difficult to understand the effects of seizure related variables due to the fact that they are 
inter-related. Polytherapy, early age of onset, and poor seizure control are frequently inter-
related and can be confounding (e.g., an individual with poor seizure control may be placed 
on multiple anti-epileptic medications and younger age of onset is associated with 
uncontrollable seizures) (Austin & Caplan, 2007). Additionally, Austin and Caplan (2007) 
note that a child’s chronological age might also be confounded by duration of illness and 
age of onset (e.g., a younger child would have an early age of onset and likely shorter 
duration). 
 In a recent review of anxiety in youth with epilepsy, Reilly, Kent, and Neville 
(2013) concluded that some seizure variables, such as taking more than one AED, high 




on measures of anxiety. Other seizure variables, such as seizure type, age of seizure onset, 
and duration of epilepsy were not related to anxiety, but these findings were inconsistent 
across studies (Reilly et al., 2013).  In a review of psychiatric disorders in children and 
adolescents with epilepsy, Dunn and Austin (2004) suggested that seizure syndrome, 
seizure severity, seizure frequency, AEDs, and family variables such as family mastery and 
control might be important variables to consider. They also indicated that seizure type was 
inconsistently predictive of psychiatric disorders (Dunn & Austin, 2004). It is clear that 
some seizure related variables may affect psychopathology and anxiety in children with 
epilepsy. However, sample sizes have been small and there are relatively few studies that 
examine anxiety in youth with epilepsy. More research is needed to determine whether 
seizure related variables have a direct effect on psychopathology or if they moderate or 
mediate other psychosocial variables.  
Demographic variables. Age, gender, and ethnicity are consistently examined to 
determine whether there are differences in levels of anxiety based on these demographic 
variables. Oguz and colleagues (2002) found that younger children (ages 9-11) had higher 
ratings of trait anxiety while adolescents (ages 12-18) had higher levels of both state and 
trait anxiety. In a population-based study of 69 children with active epilepsy, researchers 
found that anxiety symptoms were higher for older children (Reilly, Atkinson, Chin, et al., 
2015). In a study of 180 youth with epilepsy, older age and female gender both significantly 
predicted anxiety (Schraegle & Titus, 2017a). Schraegle and Titus (2017b) found that 




(older), sex (females), and race/ethnicity (minorities). Williams et al. (2003) also found 
that ethnicity was a predictor of anxiety in children with epilepsy. In a study of 69 children 
with absence epilepsy and 103 controls, Caplan and colleagues (2008) found that girls were 
5.8 times more likely to have anxiety than boys. Age and gender appear to be important 
demographic variables to consider when examining anxiety in youth with epilepsy. 
Cognitive ability. Cognitive ability is also an important variable to consider when 
examining anxiety in youth with epilepsy. In a study comparing 171 kids with epilepsy, 
Caplan et al. (2015) found that children with epilepsy who had co-occurring affective and 
anxiety disorders had significantly lower IQs compared to children with epilepsy and no 
disorder. In a study of 164 youth with epilepsy, researchers found that there were more 
mental health problems in the group of children with low IQ (Buelow et al., 2003). 
Researchers have also found that comorbid learning problems are related to anxiety in 
youth with epilepsy (Williams et al., 2003). Cognitive factors are likely confounded by 
seizure related variables; for example, youth with epilepsy and a high IQ are more likely 
to have a shorter duration of illness and less severe seizures (Buelow et al., 2003).   
Stigma. Individuals with epilepsy experience high levels of stigma, however, 
research examining the relationship between stigma and anxiety in youth with epilepsy is 
severely limited. Davies and colleagues (2003) suggest that there are higher rates of 
psychiatric diagnoses in children with epilepsy compared to other chronic illnesses because 
of the social stigma of epilepsy. Youth with epilepsy are also at risk for peer rejection, 




of stigma are related to greater child fear and worry about seizures (Austin et al., 2014). 
Additionally, parent and adolescent perceptions of stigma were both significant predictors 
of anxiety symptoms in a sample of 102 adolescents in Nigeria (Adewuya & Ola, 2005). 
Evidence of the role of stigma in anxiety is sparse, but preliminary evidence suggests a 
relationship between anxiety and perceptions of stigma.  
Family variables. Family factors, such as parent-child relationships, family 
adaptation, parental psychopathology, and family stressors, play an important role in the 
development of anxiety in children with epilepsy. Only one study to date has examined the 
association between parent-child relationships and psychopathology in youth with 
epilepsy. Positive parent-child relationships were related to lower parent reported 
symptoms of internalizing and externalizing problems in children with epilepsy, while 
parental rejection led to increased ratings of internalizing and externalizing problems 
(Rodenburg et al., 2006). Rodenburg and colleagues (2006) also found that parental 
rejection mediated the relationship between problems with family adaptation and 
symptoms of anxiety and depression, meaning that poorer family adaptation leads to parent 
rejection which ultimately leads to more symptoms of anxiety/depression (Rodenburg et 
al., 2006). In general, family stressors are associated with higher rates of anxiety in youth 
with epilepsy (Adewuya & Ola, 2005; Schraegle & Titus, 2017a). 
Parent history of psychopathology is another important predictor of child anxiety 
due to its genetic and environmental influences. In a recent review, Jones and Reilly (2016) 




anxiety.  In a study of 88 children with recent-onset of epilepsy and 49 health controls, 
71% of children with epilepsy who were diagnosed with anxiety had a family member with 
a history of anxiety or depression, which was significantly different when compared to 
children with epilepsy without anxiety (37%) and control subjects (25%) (Jones et al., 
2015). Adewuya and Ola  (2005) also found that youth anxiety was related to parental 
psychopathology. In a recent analysis of 180 children with epilepsy, Schraegle and Titus 
(2017a) found that parental psychiatric history was related to a 3-fold risk for anxiety; this 
increased to a 4-fold risk for anxiety in the context of intractable epilepsy. Schraegle and 
Titus (2017a) also found that the factors that contribute to anxiety differ in the context of 
parental anxiety (e.g., AEDs were related to anxiety in those children with a parent with no 
psychiatric history, but AEDs were unrelated to anxiety in children with a parent with 
psychiatric history). Parent anxiety is common in children with epilepsy and it is associated 
in lower quality of life (C. Jones & Reilly, 2016; Schraegle & Titus, 2017b). Despite the 
importance of family factors on child anxiety in the literature, research in youth with 
epilepsy is limited.  
 Anxiety and health related quality of life in epilepsy. Health related quality of 
life (HRQoL) is an individual’s perceptions of quality of life relative to their health or 
disease status (Bakas et al., 2012). In a prospective, community-based study, psychiatric 
comorbidity in child-onset epilepsy was more highly correlated with HRQoL than 
remission status (Baca, Vickrey, Caplan, Vassar, & Berg, 2011). Additionally, Baca and 




worse HRQoL, while externalizing symptoms had no relationship to HRQoL. In a study of 
60 children with epilepsy in Serbia, researchers found that depression, generalized anxiety 
symptoms, and separation anxiety symptoms had the most significant impact on quality of 
life compared to other demographic and epilepsy variables (Stevanovic et al., 2011). When 
examining domains of quality of life, lower internalizing symptoms were related to better 
physical and emotional quality of life (Loiselle et al., 2016). In a study of HRQoL in 109 
children with pediatric epilepsy after surgery, researchers found that improved seizure 
freedom in the last twelve months was associated with better HRQoL and that symptoms 
of anxiety and depression mediated this relationship; in other words, seizure freedom led 
to better parent ratings of anxiety and depression which led to better HRQoL (Puka & 
Smith, 2015). Symptoms of anxiety in youth with epilepsy have significant effects on 
quality of life. 
Statement of the Problem and Purpose 
There are a multitude of factors that put youth with epilepsy at an increased risk of 
anxiety, including biological, psychosocial, demographic, and family factors; these factors 
likely interact and influence each other. Despite the clear relationship between anxiety and 
epilepsy, anxiety has been considered the “forgotten” disorder in epilepsy research and has 
been overshadowed by research in depression (Clary, 2014). In the research that has been 
conducted about anxiety in youth with epilepsy, there has been no underlying theoretical 
background for the selection of variables and researchers have used inappropriate measures 




underdiagnosed and only a third of diagnosed children actually receive mental health 
services (Caplan et al., 2005). Furthermore, a recent ILAE Task Force Report suggested 
that it is important to assess for reversible causes of anxiety (Dunn et al., 2016). Examining 
family factors and psychosocial difficulties associated with anxiety in youth with epilepsy 
is especially important because it may help to identify accessible and modifiable targets 
for intervention. There is a clear need for more research investigating the risk and 
protective factors for anxiety in youth with epilepsy. This proposed research study will 
examine how seizure severity and parent factors (i.e., history of psychopathology, illness 
cognitions, and perceptions of stigma) interact to influence anxiety in youth with epilepsy. 
Research Questions and Hypotheses 
Research question 1. To what extent do parent factors influence anxiety in youth 
with epilepsy? 
Hypothesis 1a. Youth with epilepsy who have a parent with a history of 
psychopathology will have more parent reported anxiety features. 
Rationale 1a. Parent psychopathology is an important predictor of child anxiety 
due genetic and environmental factors. Heritability estimates are in the range of 30-40% 
for anxiety (Hettema et al., 2001; Micco et al., 2009). Parent history of psychopathology 
may also lead to environmental factors (e.g., socialization, modeling, and accommodation) 
that make children more vulnerable to anxiety (Murray et al., 2009). In the general 
population, children of parents with anxiety are four times more likely to have anxiety than 




have parents with a history of psychopathology are also at increased risk for anxiety 
(Adewuya & Ola, 2005; Jones et al., 2015; Schraegle & Titus, 2017a).  
Hypothesis 1b. Elevated parent perceptions of stigma will be related to increased 
parent reported anxiety features in youth with epilepsy. 
Rationale 1b. Many researchers have hypothesized that higher rates of anxiety in 
youth with epilepsy are related to the social stigma of epilepsy (Davies et al., 2003; 
Hermann et al., 1988). However, relatively few studies have systematically examined this 
issue. Some researchers have found that higher perceptions of stigma are related to more 
worry (Austin, MacLeod, Dunn, Shen, & Perkins, 2004; Austin et al., 2014) and one 
research group found that anxiety was predicted by both parent and adolescent perceptions 
of stigma (Adewuya & Ola, 2005). Parents with higher perceived stigma may also engage 
in more overprotective parenting behaviors that increase the risk for anxiety in children 
(Anthony, Gil, & Schanberg, 2003). 
Hypothesis 1c: Negative parent illness cognitions will be related to increased parent 
reported anxiety features in youth with epilepsy. 
Rationale 1c. Parent illness cognitions, particularly cognitions of helplessness, may 
lead to higher rates of anxiety in children through several pathways, including increased 
parent distress, modeling of anxious cognitions and behaviors, and parenting behaviors. 
Negative parent illness cognitions and difficulty coping with a child’s illness are related to 
parent distress, which is associated with emotional distress in the child (Colletti et al., 2008; 




Phipps, 2004). Parents with cognitions of helplessness may model anxious behavior and 
influence illness cognitions in their child (Burstein & Ginsburg, 2010) and individuals with 
poor illness cognitions have poorer emotional health (Hudson, Bundy, Coventry, & 
Dickens, 2014). A parent’s feelings of helplessness might also influence the child’s 
perceptions of control over their environment (Chorpita & Barlow, 1998). Parents may also 
engage in parenting behaviors, such as overprotection, which can make a child more 
vulnerable to anxiety by limiting the child’s engagement in the environment (Anthony et 
al., 2003).  
In contrast to parent cognitions of helplessness, parent cognitions of acceptance 
may be related to less distress, positive modeling, and parenting behaviors that are 
protective factors for child anxiety. Parents who engage in acceptance cognitions may be 
less distressed, which is associated with better emotional adjustment in children (Nicolaas 
et al., 2016). Additionally, parents with cognitions of acceptance may model more adaptive 
coping behavior and cognitions and engage in parenting behavior that allows the child to 
engage in behaviors that increase their perceptions of control over their environment 
(Burstein & Ginsburg, 2010; Chorpita & Barlow, 1998). 
Research question 2. To what extent do parent factors mediate the effect of parent 
history of psychopathology on anxiety in youth with epilepsy? 
Hypothesis 2a: Parent perceptions of stigma will partially mediate the effect of 





Rationale 2a. Parents with a history of psychopathology will have more perceptions 
of stigma, which will impact their ratings of child anxiety. Parents with more negative 
mood are more likely to report greater perceptions of stigma (Austin et al., 2004). Parent 
history of psychopathology will lead to negative perceptions of stigma, which will 
ultimately lead to higher ratings of anxiety in youth with epilepsy.  
Hypothesis 2b: Negative parent illness cognitions will partially mediate the effect 
of parent history of psychopathology on parent reported anxiety features in youth with 
epilepsy. 
Rationale 2b. Parents with a history of psychopathology will have more negative 
illness cognitions, which will impact their ratings of child anxiety. Parents who are 
clinically distressed have more cognitions of helplessness and fewer cognitions of 
acceptance (Nicolaas et al., 2016). Additionally, parent cognitions of helplessness are 
correlated with worse psychological well-being, while parent cognitions of acceptance are 
associated with better psychological well-being (Nicolaas et al., 2016). Parent history of 
psychopathology will lead to negative illness cognitions, which will ultimately lead to 
higher ratings of anxiety features in youth with epilepsy.  
Research question 3. To what extent does seizure severity influence the impact of 
parent factors on anxiety in youth with epilepsy? 
Hypothesis 3a. Seizure severity will moderate the effect of parent history of 




Rationale 3a. This hypothesis is supported by Austin et al. (2004), who found that 
greater parent perceptions of stigma are associated with greater seizure severity.  
Additionally, Schraegle and Titus (2017a) found differential effects of AEDs for parents 
with and without a history of psychopathology. AEDs were related to anxiety in youth 
without a parent with a history of psychopathology, but AEDS were not related to anxiety 
in youth with a parent with a history of psychopathology (Schraegle & Titus, 2017a). There 
may be a similar interaction between parent history of psychopathology and seizure 
severity on parent perceptions of stigma. Parents with a history of psychopathology might 
have higher perceptions of stigma regardless of their child’s seizure severity, while parents 
with no history of psychopathology may only be at risk of higher perceptions of stigma in 










Figure 3: Hypothesized moderation on parent perceptions of stigma. This figure 
illustrates the hypothesized interaction between parent history of 
psychopathology and seizure severity on parent perceptions of stigma. The 
red line represents the hypothetical regression of seizure severity on parent 
perceptions of stigma in parents with a history of psychopathology, while the 
blue line represents the hypothetical regression of seizure severity on parent 
perceptions of stigma in parents without a history of psychopathology. A 
higher score indicates more negative perceptions of stigma. 
Hypothesis 3b. Seizure severity will moderate the effect of parent history of 
psychopathology on parent illness cognitions.  
Rationale 3b. AEDs are a predictor of anxiety in youth with a parent with no history 
of psychopathology, while AEDs are not a predictor of anxiety in youth with a parent with 
a history of psychopathology (Schraegle & Titus, 2017a). Seizure severity may have a 
similar interaction with parent history of psychopathology on parent illness cognitions. 
Parents without a history of psychopathology may be more vulnerable to negative illness 
cognitions in the context of greater seizure severity, while parents with a history of 
psychopathology may be more susceptible to negative coping cognitions regardless of the 
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Figure 4: Hypothesized moderation on parent illness cognitions. This figure illustrates 
the hypothesized interaction between parent history of psychopathology and 
seizure severity on parent illness cognitions. The red line represents the 
hypothetical regression of seizure severity on parent illness cognitions in 
parents with a history of psychopathology, while the blue line represents the 
hypothetical regression of seizure severity on parent illness cognitions in 
parents with a history of psychopathology. A lower score indicates more 
negative illness cognitions. 
Research question 4. To what extent do family factors, anxiety, and seizure 
severity influence quality of life in youth with epilepsy? 
Hypothesis 4. Increased seizure severity, features of anxiety, parent perceptions of 
stigma, and negative parent illness cognitions will be related to decreased health related 
quality of life in youth with epilepsy. 
Rationale 4. Many seizure variables, including polytherapy and increased seizure 
frequency, have been associated with decreased quality of life in youth with epilepsy (Baca 
et al., 2011; Conway et al., 2016; Puka & Smith, 2015). Internalizing symptoms, such as 
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individuals with epilepsy (Baca et al., 2011; Conway et al., 2016; Loiselle et al., 2016; 
Puka & Smith, 2015; Reilly, Atkinson, Das, et al., 2015b; Stevanovic et al., 2011). 
Moreover, some researchers suggest that internalizing symptoms have the most significant 
effect on quality of life (Stevanovic et al., 2011) and that anxiety and depression mediate 
the relationship between seizure control and quality of life (Puka & Smith, 2015). Research 
into the effect of family factors is more limited, but some research suggests that parent 
anxiety is associated with decreased quality of life (Jones & Reilly, 2016; Schraegle & 
Titus, 2017a). 
Hypothesized model. Taken together, these hypotheses suggest that anxiety may 
influenced by parent factors in several ways. First, parent history of psychopathology is 
hypothesized to have a direct influence on anxiety through genetic and environmental 
factors. Parent illness cognitions and parent perceptions of stigma are also hypothesized to 
influence anxiety, and these parent factors are hypothesized to partially mediate the relation 
between parent history of psychopathology and anxiety. Finally, seizure severity is 
hypothesized to moderate the impact of parent history of psychopathology on parent 





Figure 5: Hypothesized model including parent perceptions of stigma. This figure 
illustrates the hypothesized relations between parent history of 
psychopathology, parent perceptions of stigma, seizure severity, and anxiety 
in pediatric epilepsy. 
 
Figure 6: Hypothesized model including parent illness cognitions. This figure illustrates 
the hypothesized relations between parent history of psychopathology, parent 
perceptions illness cognitions, seizure severity, and anxiety in pediatric 
epilepsy. 
 
It is important to note that this is a cross-sectional study and the data used in this 
research are nonexperimental in nature; there was no experimental manipulation of seizure 




psychopathology to determine their subsequent effect on parent reported anxiety. 
Therefore, all statements that discuss the “effect” or “influence” of one variable on another 
are dependent on the validity of this model. “If the model is a reasonable representation of 
reality, the estimates resulting from the model indeed show the extent of the influence of 
one variable on another. If the model is not a reasonable representation of reality, the 







Chapter 3: Methods 
Participants 
 Participants in this study included 121 children and adolescents with epilepsy who 
were referred to a tertiary outpatient clinic in Central Texas by their neurologists for a 
neuropsychological evaluation to assist with treatment planning. Youth were considered 
for inclusion in the study if they were between the ages of 6-18 and were diagnosed with 
epilepsy by a neurologist. Youth were excluded from the study if the caregiver or child did 
not speak English or if the parent or caregiver did not consent for their child’s information 
to be used for research purposes.  
Procedures 
 Parents of youth with epilepsy who were referred for neuropsychological 
evaluation were consented during the assessment intake. The primary caregiver was asked 
to complete an intake questionnaire and measures related to their child’s health and 
epilepsy. All parents also completed a clinical intake interview regarding their child’s 
medical, psychosocial, and family history with a licensed psychologist. Medical records 
were reviewed for all patients whose parents provided written and oral consent for their 
results to be used for research purposes. Institutional review board approval was obtained 





 Demographic information. Demographic information was obtained via review of 
medical records, intake questionnaires, and parent interviews. Variables included: gender, 
race/ethnicity, child’s age, and maternal education (coded as 1= less than high school, 
2=high school degree, 3= some college, 4=college degree, 5=graduate degree).  
Seizure information. Seizure-related variables were extracted from medical 
records, intake questionnaires, and parent interviews. Variables included: age at seizure 
onset, duration of epilepsy, number of AEDs (coded as 0=no AED treatment, 
1=monotherapy, 2=polytherapy), seizure frequency (coded as 0=none in past year, 
1=yearly, 2=quarterly or monthly, 3=weekly or daily), epilepsy type (coded as 0=no 
seizures in the past year, 1=absence seizures, 2=focal seizures, 3=generalized tonic-clonic, 
4=multiple seizure types), and intractability status (coded as 0=not intractable and 
1=intractable, using the ILAE task force definition of drug-resistant epilepsy) (Kwan et al., 
2010). Seizure severity was a composite variable, similar to the approach of Rodenberg et 
al. (2006) and Austin et al. (1996), calculated as a sum of the values for epilepsy type, 
number of AEDs, and seizure frequency.  
Parent history of psychopathology. Information regarding parent history of 
psychopathology was obtained from family history reported by parents on the intake 
questionnaires and parent interviews. Parent psychiatric history was reviewed for presence 




Anxiety. Anxiety was measured using Parent Rating Scales (PRS) from the 
Behavior Assessment System for Children (BASC) second and third editions (Kamphaus 
& Reynolds, 2015; Reynolds & Kamphaus, 2004). A majority of parents completed the 
BASC-3 (n=76; 62.8%). The BASC-3 contains all of the same items found on the BASC-
2 and includes some additional items. The BASC-2 and BASC-3 anxiety scales are very 
highly correlated (r=0.97-0.98) (Kamphaus & Reynolds, 2015). The BASC PRS Child 
Form (ages 6:0-11:11) and the PRS Adolescent Form (ages 12:0-21:11) were used 
depending on the age of the child during the assessment. The BASC PRS anxiety scale has 
11 to 14 items that the parent rated according to the frequency of their child’s behavior 
(never, sometimes, often, or almost always). Raw scores were converted to T-scores, with 
T-scores of 60-69 considered in the “at risk” range and T-scores ≥70 considered in the 
“clinically significant” range. 
The BASC-2 was normed using 1,800 parents for each form version and the sample 
was designed to represent the US population (from the 2001 Current Population Survey) 
with respect to gender, race/ethnicity, socioeconomic status, geographic region, and special 
education classification. The anxiety scale has good internal-consistency reliability 
(coefficient alpha ranging from 0.81-0.85) and test-retest reliability (corrected r=0.73-
0.86). Inter-rater reliability is moderate (corrected r=0.66-0.80) (Reynolds & Kamphaus, 





The BASC-3 was normed using 600 parents for each form version and the sample 
was designed to represent the US population with respect to gender, race/ethnicity, 
socioeconomic status, geographic region, and special education classification. The anxiety 
scale has good internal-consistency reliability (coefficient alpha ranging from 0.83-0.89) 
and test-retest reliability (corrected r=0.85-0.90). Inter-rater reliability is moderate 
(corrected r=0.54-0.65) (Kamphaus & Reynolds, 2015). The standard error of 
measurement ranges from 3.32 to 4.12 (Kamphaus & Reynolds, 2015). 
In terms of validity, the BASC has good internal structure. There are low to 
moderate correlations between the BASC-3 anxiety scale and the AESEBA 
Anxiety/Depression scale (r= 0.46-0.63) and between the BASC-2 anxiety scale and the 
AESEBA Anxiety/Depression scale (r= 0.48-0.71). The BASC PRS has been widely used 
in research with pediatric epilepsy populations (Bender et al., 2008; Titus, Kanive, Sanders, 
& Blackburn, 2008; Vega et al., 2011).  
 Stigma. Parent perceptions of stigma were assessed using the Epilepsy Stigma 
Scale (Austin et al., 2004). Stigma was defined by the authors of the measure as “referring 
to an attribute (i.e., seizure condition) held by a person that leads to his or her being 
discredited or devalued by others” (Austin et al., 2004). The parent version of the form 
measures parent perceptions of how epilepsy affects others’ perceptions of their child 
(Austin et al., 2004). The parent version of the Epilepsy Stigma Scale consists of five items 
rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree), 




differently.” The items were summed and divided by the number of items to provide a 
stigma score; a higher score reflected greater perceptions of stigma related to epilepsy 
(Austin et al., 2004).  
The psychometric properties of the scale were assessed with 171 parents of children 
(ages 9-14) with chronic epilepsy and 224 parents of children (ages 4-14) with new-onset 
epilepsy. Factor analysis of the stigma scale revealed that one factor accounted for 100% 
of the variance, factor loadings for each question ranged from 0.63 to 0.84, and found flat 
scree plots after the first factor; this suggests that the scale measures one unitary construct 
(Austin et al., 2004). The Epilepsy Stigma Scale also demonstrates good internal 
consistency (coefficient alpha ranging from 0.77-0.79) (Austin et al., 2004). In this sample, 
the Epilepsy Stigma Scale demonstrated good internal consistency (Chronbach’s alpha 
0.79). Overall, the Epilepsy Stigma Scale has good psychometric properties and appears to 
measure one construct. 
 Illness cognitions. Parent illness cognitions were measured using the Illness 
Cognition Questionnaire-Parent Version (ICQ-P) (Nicolaas et al., 2016). The ICQ-P was 
adapted from the Illness Cognition Questionnaire (ICQ), which was originally developed 
for adults with chronic health conditions (Evers et al., 2001). The ICQ-P measures a 
parent’s cognitions about how they evaluate their child’s illness. The ICQ-P consists of 
three subscales: helplessness (e.g., my child’s illness prevents me from doing what I would 
really like to do), acceptance (e.g., I can cope effectively with my child’s illness), and 




(Nicolaas et al., 2016). The ICQ-P consists of 18 items rated on a 4-point Likert scale (1= 
not at all, 2=somewhat, 3=to a large extent, 4=completely). The scores are calculated by 
summing the items scores; subscale scores range from 6 to 24 and the total score ranges 
from 18 to 72.  
 The psychometric properties of the scale were originally assessed with 242 parents 
of children aged 0 to 17 with cancer (Nicolaas et al., 2016). Factor analysis revealed that 
three factors accounted for 59.1% of the variance. Each subscale has adequate internal 
consistency (Chronbach’s alpha 0.80-0.88) (Nicolaas et al., 2016). In this sample, it also 
demonstrated adequate internal consistency for the total score (Chronbach’s alpha 0.71) 
and for each subscale (Chronbach’s alpha 0.71-0.86). Parent cognitions of helplessness 
were moderately correlated with worse psychological well-being and parents who were 
clinically distressed had more cognitions of helplessness (Nicolaas et al., 2016). Parent 
cognitions of acceptance were moderately to highly associated with better psychological 
well-being and parents who were clinically distressed had fewer cognitions of acceptance 
(Nicolaas et al., 2016). The ICQ-P has been used within the epilepsy population 
(McLaughlin, Schraegle, Nussbaum, & Titus, 2016; McLaughlin, Schraegle, & Titus, 
2017). 
 Quality of life. Health related quality of life (HRQOL) was measured using the 
Quality of Life in Childhood Epilepsy (QOLCE) and the Quality of Life in Childhood 
Epilepsy-55 (QOLCE-55), which are both parent reported measures of quality of life 




The QOLCE consists of 91 items rated on a five-point Likert scale ranging from 
“very often” or “all of the time” to “never” or “none of the time;” other questions range 
from “yes, limited a lot” to “no, not limited” and “excellent” to “poor,” depending on item 
content. The QOLCE measures HRQOL across a variety of functional life domains, 
including: physical functioning, emotional well-being, cognitive functioning, social 
functioning, and behavior (Sabaz et al., 2000). The QOLCE-55 was developed using a 
principal component analysis of the QOLCE to reduce the number of items (Goodwin, 
Lambrinos, Ferro, Sabaz, & Speechley, 2015). The QOLCE-55 consists of 55 items rated 
on a five-point Likert scale ranging from “very often” or “all of the time” to “never” or 
“none of the time;” other questions range from “yes, limited a lot” to “no, not limited,” 
depending on item content. Factor analysis of the QOLCE-55 indicated a four-factor model 
of HRQOL, including cognitive, emotional, social, and physical domains. The overall 
QOLCE-55 score demonstrates high internal consistency (Cronbach's alpha =0.96), and 
the individual subscales have similarly robust internal consistency (Cronbach's alpha = 
0.82-0.97) (Goodwin et al., 2015). Convergent validity with theoretically similar constructs 
is adequate (ρ = 0.38) (Goodwin et al., 2015).  
Most parents completed the QOLCE-55 (n=82; 67.8%); however, for those that 
completed the QOLCE, items were extracted and re-scored according to the QOLCE-55 
due to its stronger psychometric properties (Goodwin et al., 2015). The QOLCE-55 was 




scores indicate a higher level of HRQOL. An overall quality of life score was calculated as 
the sum of scores from all domains.  
 Cognitive functioning. Intelligence was assessed using the Wechsler Adult 
Intelligence Scale-IV (WAIS-IV), the Wechsler Intelligence Scale for Children-IV (WISC-
IV), the Wechsler Intelligence Scale for Children-V (WISC-V), or the Kaufman 
Assessment Battery for Children, Second Edition (KABC-II) based on the age of the child 
at the time of testing and clinical judgment. The Wechsler intelligence scales and the 
Kaufman Assessment Battery for Children are widely used measures of cognitive 
functioning. The KABC-II is designed for use with children between the ages of 3:0 and 
18:11. WISC-IV and WISC-V are designed for use with children between the ages of 6:0 
and 16:11 and the WAIS-IV is designed for use in individuals between the ages of 16:00 
and 90:11.  
 The WISC-IV and WISC-V were both normed on samples of 2,200 children 
stratified on U.S. Census data (March 2000 for WISC-IV and October 2012 for WISC-V) 
to match population characteristics related to age, sex, race/ethnicity, geographic region, 
and self or parent education level. The WAIS-IV was normed on a sample of 2,200 adults 
stratified by U.S. Census data (October 2005) to match population characteristics related 
to age, sex, race/ethnicity, geographic region, and parent education level. The Full Scale 
IQ (FSIQ) is a measure of global cognitive ability that is derived from seven subtests from 
the WISC-V and WISC-IV. The FSIQ on the WAIS-IV is derived from ten subtests. The 




IV, the WISC-V, and the WAIS-IV, respectively. The corrected r for test-retest reliability 
for the FSIQ is 0.91, 0.92, and 0.96 for the WISC-IV, the WISC-V, and the WAIS-IV, 
respectively (Wechsler, 2003, 2008, 2014). The KABC-II was normed on a sample of 
3,025 children stratified on U.S. Census data (2001) to match population characteristics 
related to gender, ethnicity, parent education, geographic region, and educational and 
psychological classification (Kaufman & Kaufman, 2004). The Fluid-Crystalized Index 
(FCI) is a composite measure of cognitive ability that is derived from ten subtests on the 
KABC-II. The reported split-half reliability coefficient for the FCI on the KABC-II ranges 
from .94 to .97. The adjusted r for test-retest reliability of the FCI on the KABC-II ranges 
from .90 to .94 (Kaufman & Kaufman, 2004). 
 Most youth were assessed using the WISC-V (n=73; 60.4%). However, due to the 
necessity to assess patients with epilepsy with the same instrument before and after 
epilepsy surgery, some patients were administered the WISC-IV (n=8; 6.4%). There are 
many similarities between the two versions of the WISC, but some of the subtests are not 
identical and they were normed on different populations. The developers report strong 
correlations between the FSIQ index on the WISC-IV and the WISC V (corrected r of 0.86) 
(Wechsler, 2003, 2014). Some younger children were administered the KABC-2 (n=15; 
12.4%), and there are moderate correlations between the FCI index on the KABC-II and 
the FSIQ on the WISC-IV and the WISC V, (adjusted r=0.89 and r=0.81, respectively) 
(Kaufman & Kaufman, 2004; Wechsler, 2014). Older adolescents were administered the 




the WAIS-IV and the WISC-IV (corrected r of 0.91) and between the WAIS-IV and the 
WISC-V (corrected r of 0.89) (Wechsler, 2003, 2008, 2014). 
Analyses 
Preliminary analyses. Preparation of the data and preliminary analyses were 
conducted using SPSS 22.0. Results of a power analysis indicated that to detect a small to 
medium effect size of f2 = 0.1 with power of 0.80 at an alpha level of 0.01 a total of 121 
participants were necessary (Faul, Erdfelder, Lang, & Buchner, 2007). Estimates for a 
sample size needed for a bias-corrected bootstrap with a medium effect size for the a path 
and a small to medium effect size for the b path was approximately 116 (Fritz & 
MacKinnon, 2007). Descriptive statistics (means, ranges, standard deviations, minimum 
and maximum values) were calculated for each of the criterion variables. Correlations 
between all variables were also assessed.  
Analysis of the research questions. Analyses consisted of a series of multiple 
regressions and tests of mediation and moderation using the Hayes (2013) PROCESS 
Macro in SPSS version 22.0. To ensure that no assumptions were violated, the data were 
assessed for linearity, independence of errors, homoscedasticity (variance of errors), 
normality of residuals, approximate normality of distribution, and outliers (Keith, 2014). 
Statistical assumptions were examined, and no violations were detected. The data were also 
assessed for multicollinearity by assessing tolerance (independence of independent 




PROCESS is a free statistical tool for use on SPSS that completes mediation and 
moderation analyses using path-analysis. The PROCESS mediation model uses 
bootstrapping, which is a resampling method, to determine indirect effects. Bootstrapping 
generates an “empirically derived representation of the sampling distribution of the indirect 
effect,” which is then used to generate a confidence interval for the indirect effect (Hayes, 
2013). PROCESS uses a bias-corrected bootstrap confidence interval (using 10,000 
bootstrap samples), which is a recommended approach for inferring indirect effects in 
mediation analyses (Hayes, 2013). Bootstrapping is the generally preferred method 
compared to Sobel tests (or the normal theory approach) in mediation analyses because it 
has higher power (less conservative), does not assume normality of sampling distribution, 
and tends to be more accurate (Hayes, 2013). The process mediation model is also 
preferable to the Baron and Kenny (1986) approach because it quantifies the indirect effect 
and uses an inferential test, it is more powerful, it does not require that the independent 
variable affects the dependent variable, and it allows quantification and comparison of 
different indirect effects (Hayes, 2013).  
Selection of control variables. Control variables were selected based on 
demographic factors that are related to the outcome variables of interest. Age, gender, and 
cognitive functioning (IQ) were controlled for in research questions 1-3 due to the 
relationship of these demographic factors with anxiety, stigma, and illness cognitions in 
the general and epilepsy population (Buelow et al., 2003; Caplan et al., 2005; Caplan et al., 




& Titus, 2017a; Williams et al., 2003). Cognitive functioning (IQ) was controlled for in 
research question 4 due to its known impact on quality of life in epilepsy (e.g., Conway, 
Widjaja, & Smith, 2018). 
Research question 1. To what extent do parent factors influence anxiety in youth 
with epilepsy? 
Analysis for research question 1. To test hypotheses 1a-1c, separate sequential 
multiple regression analyses were conducted. The BASC anxiety T-score was regressed on 
parent history of psychopathology (positive history or no history) controlling for IQ, 
gender, and age, on parent perceptions of stigma (average score) controlling for IQ, gender, 
and age, and on parent illness cognitions (total score) controlling for IQ, gender, and age.  
Research question 2. To what extent do parent factors mediate the effect of parent 
history of psychopathology on anxiety in youth with epilepsy? 
Analysis for research question 2. To test hypotheses 2a and 2b, mediations were 
assessed with a bias-corrected bootstrap confidence interval using the PROCESS macro 
(Hayes, 2013) to determine the indirect effect of parent history of psychopathology on the 
BASC anxiety T-score through parent perceptions of stigma (average score), controlling 
for IQ, gender, and age, and through parent illness cognitions (total score), controlling for 
IQ, gender, and age.  
Research question 3. To what extent does seizure severity influence the impact of 




Analysis for research question 3. To test hypotheses 3a and 3b, moderation was 
assessed with a simple moderation model using the PROCESS macro (Hayes, 2013). The 
PROCESS model generated the conditional effects of parent history of psychopathology 
on parent perceptions of stigma at varying levels of seizure severity controlling for IQ, 
gender, and age and the conditional effects of parent history of psychopathology on parent 
illness cognitions at varying levels of seizure severity controlling for IQ, gender, and age.  
Research question 4. To what extent do family factors, features of anxiety, and 
seizure severity influence quality of life in youth with epilepsy? 
Analysis for research question 4. To test hypothesis 4, a simultaneous multiple 
regression analysis was conducted. Total HRQOL was regressed on seizure severity, 





Chapter 4: Results 
The purpose of this study was to examine parent reported anxiety in pediatric 
epilepsy and the role of seizure severity, parent history of psychopathology, parent illness 
cognitions, and parent perceptions of stigma as well as the impact of these variables on 
Health-Related Quality of Life (HRQOL). All statistical analyses were performed using 
SPSS (version 22.0). 
Preliminary Data Analysis 
Descriptive statistics. Descriptive statistics regarding demographic characteristics, 
such as IQ, age at evaluation, gender, race/ethnicity, parent history of psychopathology, 
and maternal education can be found in Table 1.  Youth were between the ages of 6 and 18 
(M=12.43; SD=3.76). A slight majority of patients were female (57%). IQ scores ranged 
from 40 to 123 (M=78.08; SD=18.53). 28.9% of youth with epilepsy had a parent with a 












Table 1: Demographic characteristics. 
 n (%) Mean (SD) 
IQ -- 78.08 (18.53) 
Age -- 12.43 (3.76) 
Gender   
Female 69 (57) -- 
Male 52 (43) -- 
Race/Ethnicity   
White, Non-Hispanic 58 (47.9) -- 
White, Hispanic 30 (24.8) -- 
Black/African American 8 (6.6) -- 
Asian/Asian American 5 (4.1) -- 
Other 9 (7.4) -- 
Missing/Decline to state 11 (9.1) -- 
Parent history of psychopathology   
Absent 83 (68.6) -- 
Present 35 (28.9) -- 
Maternal Education   
< High school degree 5 (4.1) -- 
High school degree 26 (21.5) -- 
Some college 28 (23.1) -- 
College degree 33 (27.3) -- 
Graduate degree 15 (12.4) -- 
 
Descriptive statistics regarding epilepsy characteristics can be found in Table 2. 
Epilepsy age of onset ranged from infancy to 16 years (M=5.90; SD=4.62). Duration of 
epilepsy ranged from 2 months to 18 years (M=6.57; SD=4.27). The seizure severity 
composite ranged from 0 to 9 (M=4.83, SD=2.43). Most youth were on polytherapy 
(47.9%) or monotherapy (39.7%) antiepileptic drug treatment. A majority of youth 
experienced focal epilepsy (49.6%) and 26 patients (21.5%) did not experience a seizure 





Table 2: Epilepsy characteristics. 
 n (%) Mean (SD) 
Age of onset (years) -- 5.90 (4.62) 
Duration (years) -- 6.57 (4.27) 
Seizure severity -- 4.83 (2.43) 
Antiepileptic drug type   
None 15 (12.4) -- 
Monotherapy 48 (39.7) -- 
Polytherapy 58 (47.9) -- 
Intractability status   
Intractable 65 (53.7) -- 
Not intractable 56 (46.3) -- 
Epilepsy type   
No seizures in past year 26 (21.5) -- 
Absence 10 (8.3) -- 
Focal 60 (49.6) -- 
Generalized tonic-clonic 21 (17.4) -- 
Multiple seizure types 4 (3.3) -- 
Seizure frequency   
None in past year 26 (21.5) -- 
Yearly 12 (9.9) -- 
Quarterly 49 (40.5) -- 
Weekly or daily 34 (28.1) -- 
 
Descriptive statistics regarding the different parent reported measures can be found 
in Table 3. On the BASC, 21 parents endorsed anxiety features in the at-risk range for their 
child (T-scores 60-69; 17.4%) and 10 parents endorsed anxiety features in the clinically 
significant range for their child (T-scores ³70; 8.3%). T-scores on the BASC Anxiety scale 
ranged from 32 to 82, with mean scores in the average range (M=52.60; SD=10.77). Parent 
perceptions of stigma ranged from 1 to 4 (M=2.44; SD=0.88). Total illness cognitions 
scores ranged from 42 to 72 (M=62.16; SD=6.65). Quality of life scores ranged from 20.25 




Table 3: Parent reported questionnaires. 
 n (%) Mean (SD) 
Anxiety -- 52.60 (10.77) 
At-risk 21 (17.4) -- 
Clinically significant 10 (8.3) -- 
Stigma -- 2.44 (0.88) 
Illness Cognitions Total -- 62.16 (6.65) 
Acceptance -- 20.83 (2.95) 
Helplessness -- 8.95 (2.77) 
Perceived benefits -- 20.28 (3.85) 
Quality of Life Total -- 62.72 (15.65) 
Cognitive -- 49.67 (20.16) 
Emotional -- 72.83 (12.90) 
Social -- 74.98 (24.73) 
Physical -- 53.30 (22.22) 
 
Table 4 represents the correlation matrix of the outcome variables and all 





Table 4: Correlation matrix. 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 
1. Anxiety 1 -- -- -- -- -- -- -- -- 
2. IQ .139 1 -- -- -- -- -- -- -- 
3. Age .032  .086 1 -- -- -- -- -- -- 
4. Gender .128  .033  .056 1 -- -- -- -- -- 
5. Maternal education -.015 -.192* -.026 -.007 1 -- -- -- -- 
6. Parent history  .204*  .102  .019 -.006 -.038 1 -- -- -- 
7. Stigma  .190* -.237**  .089 -.066 .038  .101 1 -- -- 
8. Illness cognitions -.131 -.041 -.127 -.078 -.249** -.081 -.251** 1 -- 
9. Seizure severity .019 -.297**  .100  .134 .028 -.062 .384** -.190* 1 





Assumptions. The data were examined for any violations of assumptions required 
for multiple regression. Inspection of frequency distributions, histograms, Cook’s 
Distance, and box plots yielded no outliers. Assumptions of normality, linearity, and 
homoscedasticity were visually assessed and confirmed using residual scatter plots.  
Normal distribution of the residuals was confirmed via q-q plots of predicted and observed 
values.  Multicollinearity was assessed with tolerance and variance inflation factors, which 
were within normal limits.  
Main Analyses 
Research question 1. Parent history of psychopathology, elevated parent 
perceptions of stigma, and negative parent illness cognitions were expected to be related 
to increased parent reported anxiety features in youth with epilepsy. To test hypotheses 1a-
1c, separate sequential multiple regression analyses were conducted. The p-value 
associated with the change in R2 was examined at an alpha level of 0.017 (using the 
Bonferroni correction to adjust for multiple comparisons and a family-wise error rate of 
.05). 
Hypothesis 1a. Parent history of psychopathology was expected to account for a 
significant amount of variance in parent reported child anxiety among pediatric epilepsy 
patients after controlling for gender, age, and IQ.  Model statistics for all variables can be 
found in Table 5.  IQ, gender, and age accounted for 5.3% of the variance in parent reported 
child anxiety, but none of the control variables contributed significantly to the overall 




psychopathology accounted for 3.5% of the variance in parented reported child anxiety, 
but the change in R2 did not reach statistical significance after controlling for multiple 
comparisons, F Change (1, 113) = 4.356, p=.039. The semipartial correlation of parent 
reported child anxiety with parent history of psychopathology was .187. This finding 
suggests that parent history of psychopathology did not contribute uniquely to the model.   
Table 5: Parent history of psychopathology regression model. 
 B SE B b p R2 ΔR2 
Block 1 -- -- -- .100 .053 .053 
Constant 42.301 5.165 -- .000 -- -- 
IQ     .105   .053 .182 .050 -- -- 
Age    -.001   .258 .000 .996 -- -- 
Gender   2.903 1.962  .135 .142 -- -- 
Block 2 -- -- -- .032 .088 .035 
Constant 41.915 5.094 -- .000 -- -- 
IQ     .094   .053 .163 .076 -- -- 
Age    -.007   .254 -.002 .979 -- -- 
Gender   2.947 1.93  .137 .130 -- -- 
Parent Hx Psych   4.376  2.097  .188 .039 -- -- 
Note: p-value for Blocks 1 and 2 is the significance of the overall model F statistic 
Hypothesis 1b. Parent perception of stigma was expected to account for a 
significant amount of variance in parent reported child anxiety among pediatric epilepsy 
patients after controlling for gender, age, and IQ.  Model statistics for all variables can be 
found in Table 6.  IQ, gender, and age accounted for 3.5% of the variance in parent reported 
child anxiety, but none of the control variables contributed significantly to the overall 
model, F(3, 117) = 1.397, p = .247.  When added to the model, parent perception of stigma 




R2 was statistically significant, F Change (1, 116) = 7.153, p=.009. The semipartial 
correlation of parent reported child anxiety with parent perception of stigma was .237. This 
finding suggests that parent perceptions of stigma may uniquely contribute parent reported 
child anxiety features, even when demographic variables known to adversely impact child 
anxiety are taken into account.  Parents who believe that their children are stigmatized due 
to their epilepsy also rate more features of anxiety in their children.  
Table 6: Stigma regression model. 
 B SE B b p R2 ΔR2 
Block 1 -- -- -- .247 .035 .035 
Constant 44.522 5.199 -- .000 -- -- 
IQ    .078   .053  .134 .146 -- -- 
Age    .040   .262 .014 .878 -- -- 
Gender   2.651 1.972  .122 .181 -- -- 
Block 2 -- -- -- .025 .091 .056 
Constant 35.268 6.136 -- .000 -- -- 
IQ    .113   .053  .194 .037 -- -- 
Age    -.040   .257 -.014 .878 -- -- 
Gender   2.992 1.927  .138 .123 -- -- 
Stigma   3.000 1.122  .246 .009 -- -- 
Note: p-value for Blocks 1 and 2 is the significance of the overall model F statistic 
Hypothesis 1c. Parent illness cognitions were expected to account for a significant 
amount of variance in parent reported child anxiety among pediatric epilepsy patients after 
controlling for gender, age, and IQ.  Model statistics for all variables can be found in Table 
7.  IQ, gender, and age accounted for 3.5% of the variance in parent reported child anxiety, 
but none of the control variables contributed significantly to the overall model, F(3, 117) 
= 1.397, p = .247.  When added to the model, parent illness cognitions accounted for 1.3% 




statistical significance after controlling for multiple comparisons, F Change (1, 116) = 
1.612, p=.207. The semipartial correlation of parent reported child anxiety with parent 
illness cognitions was .114. This finding suggests that parent illness cognitions did not 
contribute uniquely to the model.   
Table 7: Illness cognitions regression model. 
 B SE B b p R2 ΔR2 
Block 1 -- -- -- .247 .035 .035 
Constant 44.522 5.199 -- .000 -- -- 
IQ     .078    .053  .134 .146 -- -- 
Age   .040    .262 .014 .877 -- -- 
Gender 2.651 1.972  .122 .181 -- -- 
Block 2 -- -- -- .220 .048 .013 
Constant 56.981 11.098 -- .000 -- -- 
IQ     .076    .053  .130 .155 -- -- 
Age   .000    .263 .000 1.000 -- -- 
Gender 2.475 1.972  .114 .212 -- -- 
Illness cognitions -.188 .148  -.116 .207 -- -- 
Note: p-value for Blocks 1 and 2 is the significance of the overall model F statistic 
Research question 2. Parent perceptions of stigma and parent illness cognitions 
were expected to partially mediate the effect of parent history of psychopathology on parent 
reported anxiety features in youth with epilepsy. To test hypotheses 2a and 2b, mediations 
were assessed with a bias-corrected bootstrap confidence interval using the PROCESS 
macro (Hayes, 2013). The 95% bias-corrected bootstrap confidence intervals were 
examined, and if they did not include zero the indirect effect was considered statistically 
significant.    
Hypothesis 2a. Parent perception of stigma was expected to mediate the relation 




controlling for gender, age, and IQ.  The 95% bias-corrected bootstrap confidence interval 
of the indirect effect contained zero and was not significant (95% CI: -.6734 - 2.0633), see 
Table 8.  This finding suggests that there is not a significant indirect effect of parent history 
of psychopathology on the BASC anxiety T-score through parent perceptions of stigma. 
Table 8: Stigma mediation model. 
 Effect SE*  t p LLCI* ULCI* 
Total effect 4.4317 2.2807 1.9431 .0546 -.0887 8.9520 
Direct effect 3.9537 2.2220 1.7793 .0780 -.4507 8.3582 
Indirect effect .4780 .6674 -- -- -.6734 2.0633 
*Indirect effect values show the bootstrapped SE and confidence intervals. LLCI=lower 
limit of CI; ULCI=upper limit of CI. 
 
Hypothesis 2b. Parent illness cognitions were expected to mediate the relation 
between parent history of psychopathology and parent reported child anxiety after 
controlling for gender, age, and IQ.  The 95% bias-corrected bootstrap confidence interval 
of the indirect effect contained zero and was not significant (95% CI: -.2295 - .9254), see 
Table 9.  This finding suggests that there is not a significant indirect effect of parent history 
of psychopathology on the BASC anxiety T-score through parent illness cognitions. 
Table 9: Illness cognitions mediation model. 
 Effect SE*  t p LLCI* ULCI* 
Total effect 4.4317 2.2807 1.9431 .0546 -.0887 8.9520 
Direct effect 4.3905 2.2874 1.9194 .0576 -.1436 8.9245 
Indirect effect .0412 .2405 -- -- -.2295 .9254 
* Indirect effect values show the bootstrapped SE and confidence intervals. LLCI=lower 





Research question 3. Seizure severity was expected to moderate the possible effect 
of parent history of psychopathology on parent perceived stigma and on parent illness 
cognitions. To test hypotheses 2a and 2b, moderation was assessed with a simple 
moderation model using the PROCESS macro (Hayes, 2013). The 95% bias-corrected 
bootstrap confidence intervals were examined, and if they did not include zero the 
interaction was considered significant.    
Hypothesis 3a. Seizure severity was expected to moderate the possible effect of 
parent history of psychopathology on parent perception of stigma after controlling for 
gender, age, and IQ. The 95% bias-corrected bootstrap confidence interval of the 
interaction contained zero and was not significant, p=.7091, see Table 10. This finding 
suggests that seizure severity does not moderate the relation between parent history of 
psychopathology and parent perception of stigma. 
Table 10: Effect of parent history on stigma at varying levels of seizure severity. 
 Effect/coeff SE t p LLCI ULCI R2** 
Interaction model -.0304 .0812 -.3740 .7091 -.1914 .1306 .0011 
Low severity  .2572 .2499 1.0292 .3057 -.2382 .7527 -- 
Medium severity .1851 .1844 1.0036 .3178 -.1805 .5506 -- 
High severity .1129 .2828 .3992 .6906 -.4478 .6735 -- 
*Low severity=2.5275; Medium severity=4.9035; High severity=7.2795 
** R2 is the increase in R2 due to the interaction 
 
Hypothesis 3b. Seizure severity was expected to moderate the possible effect of 
parent history of psychopathology on parent illness cognitions after controlling for gender, 




contained zero and was not significant, p=.8047, see Table 11. This finding suggests that 
seizure severity does not moderate the relation between parent history of psychopathology 
and parent illness cognitions. 
Table 11: Effect of parent history on illness cognitions at varying levels of seizure 
severity. 
 Effect/coeff SE t p LLCI ULCI R2** 
Interaction model -.1559 .6288 -.2479 .8047 -1.4024 1.0906 .0005 
Low severity  -.2790 1.9354 -.1441 .8857 -4.1157 3.5577 -- 
Medium severity -.6494 1.4278 -.4548 .6502 -3.4799 2.1811 -- 
High severity -1.0199 2.1900 -.4657 .6424 -5.3612 3.3215 -- 
* Low severity=2.5275; Medium severity=4.9035; High severity=7.2795 
** R2 is the increase in R2 due to the interaction 
 
Additional analysis. To further understand the effects of stigma and seizure 
severity on parent reported anxiety, an additional post-hoc exploratory analysis was 
completed. Seizure severity was expected to moderate the effect of parent perceived stigma 
on parent reported child anxiety after controlling for gender, age, and IQ. The 95% bias-
corrected bootstrap confidence interval of the interaction was significant, p=.0302, see 
Table 12. This finding suggests that there is an interaction between parent perceived stigma 
and seizure severity on parent reported child anxiety. As shown in Figure 7, at low levels 
of seizure severity (2.4045) there is not a significant relation between parent perceived 
stigma and parent reported child anxiety, p=.8062. However, at medium (4.8347) and high 
(7.2649) levels of seizure severity, there is a significant relation between parent perceptions 
of stigma and parent reported child anxiety (p=.0091 and p=.0008, respectively). This 




child is stigmatized rate higher features of anxiety in their children, while parents of 
children with high seizure severity who perceive less stigma rate lower features of anxiety 
in their children. In parents of children with low seizure severity, parent perceptions of 
stigma are not related to their ratings of anxiety in their children. 
Table 12: Effect of stigma on anxiety at varying levels of seizure severity. 
 Effect/coeff SE t p LLCI ULCI R2** 
Interaction model 1.1119 .5066 2.1949 .0302 .1084 2.1154 .0368 
Low severity  .4239 1.7237 .2460 .8062 -2.9906 3.8385 -- 
Medium severity 3.1260 1.1787 2.6520 .0091 .7909 5.4611 -- 
High severity 5.8280 1.6849 3.4590 .0008 2.4903 9.1657 -- 
*Low severity=2.4045; Medium severity=4.8347; High severity=7.2649 





Figure 7: Effect of stigma on anxiety at varying levels of seizure severity. This figure  
  represents the interaction between seizure severity and parent perceptions  
  of stigma on parent reported child anxiety. The blue dots and line represent  
  parent ratings of children with low seizure severity (ratings between 0 and  
  4; n= 35). The green dots and line represent parent ratings of children with  
  medium seizure severity (ratings between 5 and 6; n= 55). The orange dots  
  and line represent parent ratings of children with high seizure severity  
  (ratings between 6 and 9; n= 31). 
 
Research question 4. Seizure severity, parent reported anxiety, parent perceptions 
of stigma, and parent illness cognitions were expected to account for a significant amount 
of variance in HRQOL among youth with epilepsy after controlling for IQ. To test research 
question 4, a simultaneous multiple regression analysis was conducted. The p-value of the 




level of 0.05.  The regression model was statistically significant, F(5, 115) = 20.170, p = 
.000, and accounted for 46.7% of the variance in parent reported quality of life (R2 = 0.467, 
adj R2 = 0.444).  Model statistics for all predictor variables can be found in Table 13.  These 
results indicate that that stigma, parent illness cognitions, and parent reported child anxiety 
all uniquely contribute to HRQOL, even when IQ and seizure severity are taken into 
account.  
Table 13: Health-related quality of life regression model. 
 B SE B b p R2 
Overall model -- -- -- .000** .467 
Constant 56.539 14.574 -- .000** -- 
IQ .223 .062 .264 .001** -- 
Seizure severity -1.163 .492 -.180 .020* -- 
Stigma -6.512 1.381 -.367 .000** -- 
Illness cognitions .366 .168 .155 .032* -- 
Anxiety -.236 .103 -.163 .023* -- 
*p<.05; **p<.01 
 Additional analysis. To further understand the role of these variables on HRQOL, 
additional exploratory simultaneous multiple regression analyses were completed for each 
subscale of the QOLCE-55.  
Cognitive. The regression model for the cognitive domain was statistically 
significant, F(5, 115) = 5.487, p = .000, and accounted for 19.3% of the variance in parent 
reported quality of life in the cognitive domain (R2 = .193, adj R2 = .158). Model statistics 
can be found in Table 14. These results indicate that parent reported child anxiety 




for the child’s IQ. Parents who reported higher levels of child anxiety reported lower 
quality of life in the cognitive domain for their child. 
Table 14: Health-related quality of life cognitive domain regression model 
 B SE B b p R2 
Cognitive domain model -- -- -- .000** .193 
Constant 23.753 23.110 -- .306 -- 
IQ .405 .099 .372 .000** -- 
Seizure severity .262 .781 .032 .738 -- 
Stigma -2.396 2.189 -.105 .276 -- 
Illness cognitions .265 .267 .087 .324 -- 
Anxiety -.334 .163 -.179 .043* -- 
*p<.05; **p<.01 
Emotional. The regression model for the emotional domain was statistically 
significant, F(5, 115) = 10.694, p = .000, and accounted for 31.7% of the variance in parent 
reported quality of life in the emotional domain (R2 = .317, adj R2 = .288). Model statistics 
can be found in Table 15. These results indicate that parent perceptions of stigma and parent 
illness cognitions contribute to parent reported quality of life in the emotional domain, even 
after accounting for parent reported child anxiety and intelligence. Parents who reported 
higher perceptions of stigma and more negative illness cognitions reported lower quality 








Table 15: Health-related quality of life emotional domain regression model 
 B SE B b p R2 
Emotional domain model -- -- -- .000** .317 
Constant 61.801 13.599 -- .000** -- 
IQ .116 .058 .166 .049* -- 
Seizure severity .063 .459 .012 .891 -- 
Stigma -4.093 1.288 -.280 .002** -- 
Illness cognitions .463 .157 .239 .004** -- 
Anxiety -.325 .096 -.271 .001** -- 
*p<.05; **p<.01 
Social. The regression model for the social domain was statistically significant, F(5, 
115) = 17.095, p = .000, and accounted for 42.6% of the variance in parent reported quality 
of life in the social domain (R2 = .426, adj R2 = .401). Model statistics can be found in Table 
16. These results indicate that parent perceptions of stigma and seizure severity contribute 
to parent reported quality of life in the social domain. Parents who reported higher 
perceptions of stigma reported lower quality of life in the social domain for their child. 
Table 16: Health-related quality of life social domain regression model 
 B SE B b p R2 
Social domain model -- -- -- .000** .434 
Constant 105.785 23.889 -- .000** -- 
IQ .121 .102 .091 .238 -- 
Seizure severity -3.361 .807 -.330 .000** -- 
Stigma -9.735 2.263 -.348 .000** -- 
Illness cognitions .274 .276 .074 .322 -- 
Anxiety -.329 .169 -.143 .054 -- 
*p<.05; **p<.01 
Physical. The regression model for the physical domain was statistically 




reported quality of life in the physical domain (R2 = .390, adj R2 = .364). Model statistics 
can be found in Table 17. These results indicate that intelligence, parent perceptions of 
stigma, and seizure severity all contribute to parent reported quality of life in the physical 
domain. Parents reported lower quality of life in the social domain if their child had a lower 
IQ, more severe seizures, or if the parent reported higher perceptions of stigma. 
Table 17: Health-related quality of life physical domain regression model 
 B SE B b p R2 
Physical domain model -- -- -- .000** .390 
Constant 31.684 22.137 -- .155 -- 
IQ .261 .095 .217 .007** -- 
Seizure severity -1.521 .748 -.166 .044* -- 
Stigma -9.791 2.097 -.389 .000** -- 
Illness cognitions .481 .256 .144 .063 -- 
Anxiety .050 .156 .024 .748 -- 
*p<.05; **p<.01 
Summary 
Research question 1 examined the extent that parent factors influenced parent 
reported anxiety in youth with epilepsy. Findings suggested that parent illness cognitions 
and parent history of psychopathology did not predict parent reported child anxiety after 
controlling for gender, age, and IQ. However, parents who believed their children 
experienced more stigma related to their epilepsy rated higher anxiety in their children. 
 Research question 2 examined whether parent factors mediated the possible effect 
of parent history of psychopathology on parent reported anxiety in youth with epilepsy. 
Parent perceptions of stigma and parent illness cognitions did not mediate the relation 




 Research question 3 examined the extent that seizure severity interacted with 
parent factors to influence parent reported anxiety in youth with epilepsy. Seizure severity 
did not moderate the relation between parent history of psychopathology and parent 
perception of stigma and seizure severity did not moderate the relation between parent 
history of psychopathology and parent illness cognitions. Additional analysis revealed a 
statistically significant interaction between parent perceptions of stigma and seizure 
severity. Seizure severity moderated the relation between parent perceptions of stigma and 
parent reported child anxiety. At lower levels of seizure severity, there was not a significant 
relation between parent perceptions of stigma and parent reported child anxiety. However, 
at higher levels of seizure severity, parents who believed their children experienced more 
stigma related to their epilepsy also rated higher anxiety in their children. 
 Research question 4 examined how family factors, parent reported anxiety, and 
seizure severity influenced quality of life in youth with epilepsy. Results indicated that 
intelligence, seizure severity, parent reported anxiety, parent perceptions of stigma, and 
parent illness cognitions were all statistically significant predictors of HRQOL. See Table 
18 for a summary of which variables were statistically significant for each domain. 
Table 18: Summary of quality of life findings by domain 
 Cognitive Emotional Social Physical 
IQ ++ + - ++ 
Seizure severity - - ++ + 
Stigma - ++ ++ ++ 
Illness cognitions - ++ - - 
Anxiety + ++ - - 




Chapter 5: Discussion 
Summary  
Compared to children with other chronic health conditions, youth with epilepsy are 
considered to be at the highest risk for anxiety symptoms (Pinquart & Shen, 2011), and 
yet, research regarding risk and protective factors for anxiety in youth with epilepsy is 
sparse. The purpose of this study was to examine parent reported anxiety in pediatric 
epilepsy and the role of seizure severity, parent history of psychopathology, parent illness 
cognitions, and parent perceptions of stigma as well as the impact of these variables on 
Health-Related Quality of Life (HRQOL). Analyses consisted of a series of sequential and 
simultaneous multiple regressions and tests of mediation and moderation using the Hayes 
(2013) PROCESS Macro in SPSS version 22.0. 
Anxiety. In this sample of referred youth with epilepsy, parent reported anxiety, as 
measured by the BASC parent report, was in the average range (mean 52.60; SD 10.77). 
Additionally, over 25% of parents reported child anxiety symptoms in the at-risk (17.4%) 
or clinically significant (8.3%) range. These results are consistent with rates reported in 
other samples of youth with epilepsy (e.g., Titus et al., 2008; Williams et al., 2003) and in 
a recent meta-analysis of adults with epilepsy (Scott et al., 2017). It is important to note 
that this study relied upon one time parent report of child anxiety. Parents may under-
indentify internalizing problems in children and use of diagnostic interview (e.g., Jones et 




limitations, this study contributes to research characterizing the rates of parent reported 
anxiety in youth with epilepsy and confirms the need to further understand the risks and 
protective factors involved in the development and maintenance of anxiety in pediatric 
epilepsy. 
Parent history of psychopathology. In the literature, parent history of 
psychopathology is associated with higher risk for anxiety in the general population (e.g., 
Micco et al., 2009) and in the context of pediatric epilepsy (e.g., Jones et al., 2015; 
Schraegle & Titus, 2017a). In the current study, after adjusting for multiple comparisons, 
parent history of psychopathology did not explain a significant amount of variance in 
parent reported child anxiety. This result is unexpected, but it is likely attributable to 
limitations in study design. The use of a dichotomous variable and the lower percentage of 
parents who reported a history of psychopathology (29%) likely contributed to smaller 
power to detect differences than originally calculated in the power analysis.  
Parent perceptions of stigma. Stigma has been an overarching hypothesis for 
understanding the psychosocial reasons for higher rates of anxiety in the epilepsy 
population in comparison to healthy controls and comparable groups with chronic health 
conditions (Davies et al., 2003; Hermann et al., 1988). This study replicates previous 
findings (Austin, MacLeod, Dunn, Shen, & Perkins, 2004; Austin et al., 2014; Adewuya 
& Ola, 2005) and demonstrates that parents who rated higher perceptions of stigma 
reported more features of anxiety in their child. This suggests that children who are 




approximately 5.6% of the variance in parent reported child anxiety, and stigma may play 
a small, but important role in the development and maintenance of anxiety in pediatric 
epilepsy. 
Parent perceptions of stigma may also relate to parent reported child anxiety 
indirectly. Perhaps parents who have more perceptions of stigma may also have reduced 
perceptions of control. Chorpito and Barlow (1998) suggest that individuals can develop a 
psychological vulnerability for anxiety when they perceive events to be outside of their 
control after experiencing uncontrollable events (e.g., seizures). Field and Purkis (2011) 
theorize that children can acquire fear through verbal information or observations of others. 
If parents who perceive high levels of stigma inadvertently model their child’s epilepsy to 
be outside of their control, their children may perceive lower levels of control. Previous 
research has demonstrated that individuals who perceive lower levels of control report 
higher symptoms of anxiety (Gallagher et al., 2014).  
Parent perceptions of stigma may also relate to certain parenting behaviors that are 
associated with higher anxiety, such as overprotectiveness and accommodation (Anthony 
et al., 2003). Previous research has found that higher rates of child anxiety were reported 
when parents granted less autonomy to their child (McLeod et al., 2007). Parents who 
perceive more stigma may engage in more overprotective parenting to limit their child’s 
exposure to this perceived stigmatizing environment. Parents with higher ratings of 
perceived stigma may also contribute to their child’s anxiety by socializing them to the 




of perceived stigma may also be more likely to accommodate their child’s anxiety by 
allowing them to avoid anxiety provoking situations.  Because this study measured parent 
perceptions of stigma, and did not directly measure parenting behaviors, more research is 
needed to elucidate the connection between parenting behaviors and perceptions of stigma.  
It is also important to consider alternate hypotheses for the relation between parent 
perceptions of stigma and parent reported child anxiety. In this model, it was assumed that 
parent perceptions of stigma preceded symptoms of parent reported child anxiety. 
However, previous research demonstrates the bidirectional relationship of anxiety and 
epilepsy, in that anxiety symptoms may precede epilepsy diagnosis (N. C. Jones et al., 
2008). Therefore, it is also likely that in some cases, parent reported child anxiety 
symptoms preceded the epilepsy diagnosis and thus also preceded parent formation of 
perceptions of stigma. In these scenarios, parent perceptions of stigma may maintain or 
exacerbate parent reported anxiety symptoms. While the questions on the epilepsy stigma 
scale are placed in the context of epilepsy, parents of youth with epilepsy and anxiety may 
also be more likely to perceive higher levels of stigma. Furthermore, parents who rate 
higher perceptions of stigma may also be more inclined to rate their child’s anxiety as more 
severe. It may be difficult to disentangle parent reported perceptions of stigma with parent 
reported child anxiety, and future research should collect anxiety and stigma ratings 





Parent perceptions of stigma were also hypothesized to mediate the relation 
between parent history of psychopathology and parent reported child anxiety. However, 
this study did not find a statistically significant indirect effect; this is likely attributable to 
the smaller sample of parents with a history of psychopathology than originally anticipated. 
Additionally, this study used parent history of psychopathology, and not current levels of 
psychopathology or distress. Future research should measure current levels of parent 
psychopathology or distress. 
Parent illness cognitions. It was hypothesized that more negative parent illness 
cognitions would be associated with higher parent reported anxiety symptoms. This current 
research did not support this hypothesis. This result was unexpected because previous 
research demonstrates that negative illness cognitions regarding a child’s illness is related 
to parent distress, which, in turn, is related to more emotional distress in children (Colletti 
et al., 2008; Nicolaas et al., 2016; Robinson et al., 2007; Steele et al., 2004). While the 
Illness Cognitions Questionnaire measures an aspect of a parent’s coping and adjustment 
to their child’s illness, illness cognitions are just one component of coping. Future research 
may wish to examine other aspects of parent coping and explore the relation between parent 
illness cognitions or coping and parenting behaviors. 
It was also hypothesized that parent illness cognitions would mediate the relation 
between parent history of psychopathology and parent reported child anxiety. However, 




the previous finding that parent illness cognitions were not associated with higher parent 
reported anxiety symptoms. 
Seizure severity. Epilepsy variables have been consistently explored as possible 
causes of higher rates of anxiety in pediatric epilepsy. In this study, seizure severity was 
examined as a variable that may interact with other psychosocial variables. It was 
hypothesized that seizure severity would moderate the effect of parent history of 
psychopathology on parent perceived stigma (i.e., in the context of low seizure severity, 
parents with a history of psychopathology would report higher levels of perceived stigma, 
but in the context of high seizure severity, both parents with and without a history of 
psychopathology would report high levels of perceived stigma (see Figure 3)). A similar 
interaction was hypothesized for parent illness cognitions, in that seizure severity would 
moderate the effect of parent history of psychopathology on parent illness cognitions (see 
Figure 4). In both models, there was no interaction between parent history of 
psychopathology and seizure severity.  
This finding suggests that the relation between parent history of psychopathology 
and parent illness cognitions and parent perceptions of stigma is not dependent on seizure 
severity. While an interaction was hypothesized, this finding is not completely unexpected 
because moderation effects are rare (Keith, 2014). This study may not have been 
adequately powered to detect a moderation effect when using a dichotomous variable for 
parent history of psychopathology. Additionally, parent illness cognitions and parent 




not history of psychopathology. Future research should examine the effect of seizure 
severity on parent perceptions of stigma and illness cognitions in the context of current 
parent distress due to its relation to emotional distress in the child (Colletti et al., 2008; 
Nicolaas et al., 2016; Robinson et al., 2007; Steele et al., 2004). 
To further explore the effect of seizure severity on parent perceptions of stigma and 
parent reported child anxiety, a post hoc exploratory analysis was completed. Seizure 
severity was hypothesized to moderate the relation between parent perceptions of stigma 
and parent reported child anxiety. Results demonstrated that there was an interaction 
between parent perceptions of stigma and seizure severity on parent reported child anxiety 
(see Figure 7). This finding suggests that there is a conditional effect of parent perceptions 
of stigma on parent reported child anxiety at varying levels of seizure severity. In other 
words, at low levels of seizure severity, there was not a relation between parent perceptions 
of stigma and parent reported child anxiety. However, at higher levels of seizure severity, 
parents with more perceptions of stigma also reported higher levels of child anxiety.  
There are several reasons why this interaction between seizure severity and parent 
perceptions of stigma may occur. First, in the literature it has been demonstrated that higher 
seizure severity is associated with higher perceptions of stigma (Austin et al., 2014). 
Epilepsy is more visible in children with more severe seizures, and perhaps perceptions of 
stigma may be more internalized in these youth. Youth with greater seizure severity may 
be more susceptible to experiencing stigma related to their epilepsy, and therefore are more 




supported by Gandy et al. (2012), who hypothesized that stigma might be more important 
in individuals with poorly controlled epilepsy, while stigma is less important for 
individuals with epilepsy who have less frequent seizures.  
The interaction between parent perceptions of stigma and seizure severity may also 
indirectly affect parent reported anxiety through parenting behaviors. Parents who perceive 
high stigma may engage in more over-protective parenting, particularly when their child’s 
seizures are more severe. In contrast, low parent perceptions of stigma in parents of 
children with high seizure severity may be a protective factor for children. These parents 
with lower perceptions of stigma may model higher perceptions of control and may not be 
as over-protective. In contrast, parents of children with lower seizure severity may not need 
to engage in as much over-protective parenting. More research is needed to determine if 
parenting behaviors change in the context of higher seizure severity along varying levels 
of perceived stigma.  
It is also important to consider alternate hypotheses and note that perceptions of 
stigma and child anxiety were measured through parent report. Perhaps parents with 
children with more severe epilepsy rated more perceived stigma when their child had 
symptoms of anxiety. Alternatively, parents of children with high seizure severity who 
rated higher perceived stigma may also be more likely to rate more features of anxiety. 
Furthermore, perhaps in the context of lower levels of seizure severity, parents may not 
perceive as much stigma towards their child’s epilepsy, and therefore there is not enough 




high seizure severity, there is more variability in parent perceptions of stigma, and higher 
perceived stigma is related to higher parent reported child anxiety. 
Quality of life. It is important to consider the impact of family and psychosocial 
factors on quality of life in youth with epilepsy. Intelligence, seizure severity, stigma, 
parent illness cognitions, and parent reported child anxiety all predicted parent reported 
health related quality of life. Additionally, all of the examined variables affected quality of 
life differentially across the various domains, see Table 18. 
As demonstrated in previous research, parent reported anxiety is related to lower 
quality of life in youth with epilepsy (Baca et al., 2011; Loiselle et al., 2016; Puka & Smith, 
2015; Stevanovic et al., 2011). Not surprisingly, lower parent reported anxiety symptoms 
were related to better quality of life in the emotional domain. Many questions in the 
emotional domain relate to symptoms of anxiety (e.g., worry) and depression, so there is 
some construct overlap within this domain. However, parent reported anxiety was also an 
important predictor of health-related quality of life in the cognitive domain, even after 
accounting for the child’s IQ. A recent meta-analysis suggests that  anxiety impacts 
cognitive functioning, particularly working memory (Moran, 2016). This research 
demonstrates the need to address anxiety in order to improve a child’s quality of life. 
Parent perception of stigma was an important predictor of total health related 
quality of life, as well as quality of life in the emotional, social, and physical domains. In 
the emotional domain, parents who perceived their child as more stigmatized because of 




Parent perception of stigma was also an important predictor of quality of life in the social 
domain. The social domain also captures certain aspects of stigma, such as feelings of 
isolation and frightening others, which may demonstrate some construct overlap. However, 
children with epilepsy may also have difficulty participating in social activities (Institute 
of Medicine, 2012) and this may be compounded when they are also experiencing stigma. 
Finally, parent perception of stigma was a significant predictor of quality of life in the 
physical domain. Parents with more perceptions of stigma may engage in more 
overprotective parenting, such as limiting or restricting their child’s physical activities or 
social interactions.  
    Parent illness cognitions were a significant predictor of overall quality of life and 
more positive parent illness cognitions were related to improved quality of life in the 
emotional domain. Interestingly, parent illness cognitions were related to emotional quality 
of life, but not parent reported child anxiety. Perhaps parent illness cognitions are related 
to broader aspects of emotional functioning captured on the quality of life measure, such 
as depression and oppositional behaviors.  
It is noteworthy that seizure severity was only a significant predictor of quality of 
life in the physical and social domains. This aligns with other research in pediatric epilepsy 
and research on outcomes of epilepsy surgery that demonstrate that seizure outcomes are 
only significant predictors of quality of life in the physical and social domains (Conway, 
Widjaja, & Smith, 2018; Schraegle & Titus, 2016; Titus et al., 2013).  This suggests that 




cognitive functioning, parent illness cognitions, and parent perceptions of stigma, need to 
be addressed in order to improve quality of life in youth with epilepsy. Taken together, 
these findings suggest the multitude of psychosocial factors that are important to quality of 
life in youth with epilepsy. 
Limitations 
While this research demonstrates the importance of parent factors on parent 
reported child anxiety in youth with epilepsy, there are also several limitations to consider. 
First, it is important to note the limited generalizability of these findings as well as the 
representativeness of this sample for the epilepsy population. This research was conducted 
with a clinically referred group of youth with epilepsy. These patients were under 
consideration for epilepsy surgery and/or demonstrated a need for a neuropsychological 
evaluation. Therefore, these patients may represent a sample of youth with more severe 
epilepsy. Additionally, while this research controlled for the effects of intelligence, this 
sample of youth had a lower mean IQ (78) than the mean IQ (84.96) reported in a recent 
population-based sample of youth with epilepsy (Reilly, Atkinson, Das, et al., 2015a). The 
results of this paper should be considered in the context of this more severe patient 
population and may not be representative of the overall epilepsy community.  
 As discussed previously, this research relied upon a dichotomous variable for 
parent history of psychopathology. The use of a dichotomous variable limits the power of 




variable was based off of parent report, which might be prone to social desirability bias. 
Finally, while use of history of psychopathology may be useful in understanding the 
genetic component of anxiety, current psychopathology or parent distress would be more 
helpful in understanding how current emotional distress in the parent affects child 
outcomes.  
 It is also important to consider that this study relied upon the use of parent reported 
measures of anxiety. Research demonstrates that parents under-report internalizing 
psychopathology and that parent and child ratings are only modestly correlated 
(Achenbach, McConaughy, & Howell, 1987). This suggests that both parent and child 
ratings may need to be considered in order to more fully understand the emotional state of 
the child. Furthermore, this research relied upon measures of parent perceptions of various 
constructs and not direct measures of parent behaviors. It is unclear whether parent 
perceptions of stigma and parent illness cognitions are directly related to parenting 
behaviors, such as overprotectiveness and accommodation.  
Additionally, this research is cross-sectional in nature, limiting the understanding 
of temporal precedence. It has been hypothesized that epilepsy and anxiety have a 
bidirectional relationship and as mentioned previously, symptoms of anxiety may precede 
the diagnosis of epilepsy. This study is also limited by the fact that it did not include a 
control group comparison. 
Finally, while it was helpful to represent seizure severity as one variable, this also 




monotherapy who has daily absence seizures or a child on monotherapy with yearly 
generalized tonic-clonic seizures). The use of one variable makes it difficult to interpret 
results and make recommendations. Additionally, some constructs, such as age of onset 
and intractability status, were not used in the seizure severity variable. Difficulty 
quantifying seizure severity is an ongoing issue within epilepsy research, and more effort 
is needed to fully understand the best way to conceptualize this construct. 
Recommendations for research 
Future research should address the identified limitations in this study’s design. Use 
of a longitudinal analysis in a larger community-based sample might be helpful to elucidate 
the temporal precedence of risk and protective factors for anxiety in pediatric epilepsy. A 
population-based sample would allow for findings that can be generalized to the general 
epilepsy population and use of a larger sample size would also allow stratification based 
on variables known to be associated with anxiety, including age, gender, and IQ.  
There are also several ways limitations in measurement may also be addressed. In 
this study, anxiety was measures through the use of the BASC parent report. The BASC is 
typically a screening tool, so it would be important to use well-validated ratings of anxiety 
(e.g., MASC) or semi-structured interviews (e.g., K-SADS) in future research. Use of 
multiple informants (e.g., parent, child, clinician) across all measures would demonstrate 
whether these findings are similar across different contexts. Additionally, it would be 
beneficial to obtain direct measures of parenting behaviors (e.g., overprotectiveness, 




parent perceptions of stigma are directly related to parent behaviors or parent 
psychopathology/ emotional distress.  Finally, more research is needed to determine the 
best way to quantify seizure severity and which seizure-related variables affect 
psychosocial outcomes. 
More research is needed to understand what factors are related to an increased risk 
for anxiety and stigma in order to create modifiable targets for intervention. It would be 
interesting to conduct research that may determine whether interventions that help alleviate 
perceptions of stigma (e.g., psychoeducation) could reduce anxiety symptoms in youth 
with epilepsy. Alternatively, research examining whether treatment of anxiety can lead to 
reduced perceptions of stigma may also be beneficial. Use of longitudinal research may 
elucidate the temporal precedence of these variables.  
While parent illness cognitions were not predictors of parent reported child anxiety 
in this study, more research may be needed to demonstrate whether parent illness 
cognitions play a role in anxiety in youth with epilepsy. Preliminary evidence from the 
emotional domain of health-related quality of life suggests that parent illness cognitions 
may be related to other aspects of emotional functioning in the child, such as depression or 
behavior difficulties. Future research could use different ways to measure parent coping or 
explore the relation between parent and child illness cognitions with other aspects of 
psychosocial functioning.  
Finally, future research should focus on the relation between parenting behaviors 




perceptions, parent behaviors, such as over-protectiveness and accommodation, are related 
to child anxiety and can be modifiable targets for intervention. Parents of children with 
epilepsy could be compared to parents of children with other chronic health conditions to 
determine if there are differences in over-protectiveness or limitation of their child’s 
activities.  
Implications for clinical practice 
Neuropsychologists and other clinicians working with youth with epilepsy should 
be aware of the higher rates of anxiety within this population and implement screening 
procedures to ensure youth with epilepsy are receiving adequate services. Other studies 
highlight the lack of children with epilepsy receiving intervention for mental health needs 
(Caplan et al., 2005) and clinicians should work to provide appropriate referrals. Cognitive 
behavioral therapy, particularly the use of exposure therapy, in combination with 
medication management is the ideal treatment for anxiety (Walkup et al., 2008). Clinicians 
working with youth with epilepsy who are experiencing anxiety should be aware of the 
unique context of epilepsy when delivering intervention. The unpredictable nature of 
seizures as well as the social stigma of having seizures may be important targets for 
intervention. 
Parents may also be an important target for intervention. This current research 
suggests that parent perceptions of stigma may play an important role in the development 
or maintenance of anxiety. Clinicians may want to work with parents to understand how 




child’s anxiety. These perceptions of stigma may be particularly important in the context 
of more severe epilepsy. Alternatively, if high levels of perceived stigma and high levels 
of parent reported child anxiety are artifacts of parent distress and over-reporting, parents 
who report high levels of perceived stigma may over-report anxiety symptoms in their 
child. Parent reported measures may need to be interpreted in the context of high 
perceptions of stigma and high seizure severity. 
Finally, it is important for clinicians working with youth with epilepsy and their 
families to understand the impact anxiety and other parent factors may have on quality of 
life. While seizure severity is generally the target of intervention in pediatric epilepsy 
(and is an important aspect of overall quality of life and quality of life in the physical and 
social domains) there are other psychosocial variables that impact quality of life. Parent 
reported symptoms of anxiety are important predictors of quality of life in the cognitive 
and emotional domains and stigma was an important predictor of quality of life across the 
social, emotional, and physical domains. This suggests that stigma and anxiety may be 
important targets of intervention that can lead to improved quality of life in youth with 
epilepsy. 
 Conclusion 
The development of anxiety in pediatric epilepsy is multifactorial, and can be 
driven by biological, psychosocial, and environmental factors. The importance of family 
factors in the development and maintenance of anxiety is a burgeoning area of research in 




stigma to play an important role in parent reported anxiety in pediatric epilepsy, 
particularly in the context of high seizure severity. More research is needed to understand 
the temporal precedence of this relationship (e.g., do parent perceptions of stigma influence 
child anxiety, or are more stigmatized perceptions formed in the context of child anxiety?). 
Individuals working with youth with epilepsy should be aware of the high rates of parent 
reported anxiety and potential role of stigmatization in the development or maintenance of 
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